No definition available.
Congenital malformations of the musculoskeletal system, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
604 |
4. Check minimum number of eventsNone |
604 |
5. Include endpointsNone |
604 |
6. Filter based on genotype QC (FinnGen only) |
590 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Malformationes congenitae systematis musculosceletalis non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Congenital malformations of the musculoskeletal system, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations and deformations of the musculoskeletal system, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3921 | 2562 | 1350 |
| Only index persons | 3291 | 2268 | 1023 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.04 |
| Only index persons | 0.07 | 0.08 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 22.80 | 30.56 | 8.01 |
| Only index persons | 27.31 | 33.04 | 14.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 590 | 506 | 84 |
| Unadjusted period prevalence (%) | 0.16 | 0.18 | 0.04 |
| Median age at first event (years) | 39.28 | 39.33 | 38.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 604
- Matched controls
- 6040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
+∞
307.7
404
*
M35.7
ICD-10 Finland
Hypermobility syndrome
53.5
307.7
199
55
Z31.5
ICD-10 Finland
Genetic counselling
10.7
156.3
210
286
R4120
NOMESCO Finland
Occupational therapy
8.6
94.4
139
204
L28
ICPC
Limited function/disability (L)
5.7
83.5
204
496
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.9
81.9
150
277
Q79.00
ICD-10 Finland
Congenital anterior diaphragmatic hernia
+∞
76.7
72
*
N03AX16
ATC
[U] pregabalin
4.6
68.7
233
728
N03AX12
ATC
[U] gabapentin; oral
5.0
66.6
186
497
L99
ICPC
Musculoskeletal disease other
13.2
63.6
63
53
N06AX21
ATC
duloxetine; oral
4.8
61.6
179
491
N02AX02
ATC
tramadol; systemic, rectal
3.8
56.7
336
1510
M79.7
ICD-10 Finland
Fibromyalgia
7.4
52.8
82
125
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.7
52.4
109
223
SPAT1229
SPAT
Assessment of need for aid
7.5
52.3
81
123
R52.2
ICD-10 Finland
Other chronic pain
7.5
48.6
74
110
R4110
NOMESCO Finland
Physiotherapy
3.5
48.2
252
1023
Q79.8
ICD-10 Finland
Other congenital malformations of musculoskeletal system
+∞
46.5
44
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
8.2
45.8
64
86
A01
ICPC
Pain general/multiple sites
4.5
44.9
130
349
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.4
44.2
132
363
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
11.5
44.0
47
44
M03BX01
ATC
baclofen; systemic
10.6
43.3
49
50
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
6.4
43.2
77
135
M25.5
ICD-10 Finland
Pain in joint
3.2
43.0
325
1619
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.7
42.8
87
173
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.0
42.7
147
448
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
10.0
42.4
50
54
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
41.3
218
876
G44.0
ICD-10 Finland
Cluster headache syndrome
12.2
39.1
40
35
K07.60
ICD-10 Finland
Snapping jaw
4.5
38.5
106
272
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.5
38.4
81
166
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.0
37.3
123
361
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.0
36.7
120
350
A28
ICPC
Limited function/disability NOS
4.1
36.1
114
324
M79.1
ICD-10 Finland
Myalgia
3.2
34.8
180
705
Z3226
NOMESCO Finland
Physiotherapist
3.2
34.6
173
664
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
3.1
34.5
204
863
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
3.8
34.1
120
367
ZY010
NOMESCO Finland
Hospital outpatient
4.4
33.6
94
243
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.6
33.4
87
213
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
33.0
198
841
N06AX16
ATC
venlafaxine; oral
3.2
32.5
169
661
Z2446
NOMESCO Finland
Social worker
4.2
32.4
98
269
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
32.3
160
608
C01CA24
ATC
epinephrine; parenteral
3.8
31.2
108
326
N02AA05
ATC
oxycodone; systemic
3.6
30.5
115
367
R5110, ,
SPAT
4.5
30.3
81
202
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
30.1
261
1333
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.0
29.6
95
271
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
3.1
29.5
160
637
J45.9
ICD-10 Finland
Asthma, unspecified
2.9
29.5
176
739
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.2
29.3
52
90
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
29.1
143
538
Q79.01
ICD-10 Finland
Congenital posteriolateral diaphragmatic hernia
+∞
28.4
27
*
XF404
NOMESCO Finland
Ambulatory ECG
4.6
28.1
72
173
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
8.2
27.9
38
49
R06.0
ICD-10 Finland
Dyspnoea
2.7
27.9
203
943
Z3231
NOMESCO Finland
Registered nurse
2.7
27.8
225
1102
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.7
27.7
68
158
Z2445
NOMESCO Finland
Psychologist
4.3
27.5
76
194
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
27.4
288
1597
A02BC05
ATC
esomeprazole; systemic
2.5
26.4
282
1568
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.4
26.3
45
75
Q79.9
ICD-10 Finland
Congenital malformation of musculoskeletal system, unspecified
+∞
26.2
25
*
3007
Kela drug reimbursment
Erenumab and fremanezumab
7.2
26.2
40
59
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.1
25.8
77
208
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
25.4
87
259
N03AX11
ATC
topiramate; oral
5.4
25.1
52
104
N03AX09
ATC
lamotrigine; oral
3.9
24.8
80
228
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
24.7
316
1889
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.7
24.5
60
139
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
24.3
199
970
C07AB07
ATC
bisoprolol; oral
2.4
24.2
246
1325
R51.80
ICD-10 Finland
Headache
2.6
24.2
184
866
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.2
24.1
111
399
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
23.8
166
747
G43.3
ICD-10 Finland
Complicated migraine
5.6
23.8
47
90
M79.6
ICD-10 Finland
Pain in limb
2.4
23.8
331
2043
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
23.7
75
211
WX002
NOMESCO Finland
Sedation and analgesia
2.9
23.6
137
560
N06AA09
ATC
amitriptyline; systemic
3.8
23.6
79
231
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.3
23.6
65
165
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.1
23.3
69
185
R03DC03
ATC
montelukast; oral
2.7
23.3
166
755
M01AH01
ATC
celecoxib; oral
3.0
23.2
123
478
M25.2
ICD-10 Finland
Flail joint
8.3
23.2
31
39
R03AC02
ATC
salbutamol; inhalant
2.5
23.0
423
2931
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.1
23.0
114
427
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.7
22.9
80
241
G43.9
ICD-10 Finland
Migraine, unspecified
3.1
22.8
107
388
M22.0
ICD-10 Finland
Recurrent dislocation of patella
7.1
22.7
35
52
M24.2
ICD-10 Finland
Disorder of ligament
8.1
22.7
31
40
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
22.6
198
992
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
22.5
298
1787
A02BA02
ATC
ranitidine; systemic
2.9
22.3
119
464
UJF32
NOMESCO Finland
Coloscopy
2.6
22.0
156
705
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
21.7
181
883
R52.9
ICD-10 Finland
Pain, unspecified
3.1
21.6
103
376
G93.3
ICD-10 Finland
Postviral fatigue syndrome
18.3
21.6
33
19
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
8.6
21.5
28
34
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.6
21.5
157
719
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
21.2
106
398
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
21.0
75
229
Q79.2
ICD-10 Finland
Exomphalos
+∞
21.0
20
*
JBB11
NOMESCO Finland
Laparoscopic repair of congenital diaphragmatic hernia
+∞
21.0
20
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.0
20.7
62
167
ZXA05
NOMESCO Finland
Left side
2.6
20.7
142
630
XA402
NOMESCO Finland
ENMG
6.7
20.3
33
52
WX402
NOMESCO Finland
General anaesthesia
2.4
20.2
189
968
H02AB07
ATC
prednisone; oral
3.0
20.1
104
397
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.7
20.1
67
195
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
5.4
20.0
41
81
S43.0
ICD-10 Finland
Dislocation of shoulder joint
5.4
19.8
40
78
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
19.8
146
669
M54.6
ICD-10 Finland
Pain in thoracic spine
3.2
19.5
87
305
C08DA01
ATC
verapamil; systemic
5.1
19.5
42
87
A02BC02
ATC
pantoprazole; systemic
2.3
19.4
411
2920
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
19.4
81
273
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.1
19.3
55
143
UKC02
NOMESCO Finland
Cystoscopy
3.2
19.2
83
285
G50.1
ICD-10 Finland
Atypical facial pain
7.5
19.2
28
39
T78.4
ICD-10 Finland
Allergy, unspecified
3.6
19.1
66
197
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.7
19.0
46
105
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
19.0
255
1510
N05AH04
ATC
quetiapine; oral
2.4
19.0
169
843
N02CD01
ATC
erenumab; parenteral
8.4
18.9
25
31
Z50.1
ICD-10 Finland
Other physical therapy
4.5
18.9
47
110
L29
ICPC
Musculoskeletal sympt/complt other
3.1
18.8
88
317
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.7
18.8
45
102
G47.3
ICD-10 Finland
Sleep apnoea
2.5
18.8
145
678
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
18.5
149
709
M22.4
ICD-10 Finland
Chondromalacia patellae
4.7
18.5
44
99
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
18.4
151
725
C07AA05
ATC
propranolol; systemic
2.3
18.4
184
964
XKD00
NOMESCO Finland
Uroflowmetry
3.8
18.4
60
172
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.5
18.2
68
213
R4190
NOMESCO Finland
Nutritional therapy
3.8
18.2
59
168
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.5
18.2
46
109
M50.3
ICD-10 Finland
Other cervical disc degeneration
6.9
18.0
28
42
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.9
18.0
28
42
R11
ICD-10 Finland
Nausea and vomiting
2.9
17.9
94
361
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
17.8
56
156
H02AB06
ATC
prednisolone; systemic
2.1
17.8
303
1952
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
17.8
286
1803
Q79.10
ICD-10 Finland
Eventration of diaphragm
+∞
17.8
17
*
G44.2
ICD-10 Finland
Tension-type headache
2.5
17.8
141
666
Z2221
NOMESCO Finland
Medical doctor
2.2
17.5
219
1252
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
17.5
257
1563
M54.5
ICD-10 Finland
Low back pain
2.1
17.5
277
1733
L20
ICPC
Joint symptom/complaint NOS
4.1
17.5
50
130
JAH01
NOMESCO Finland
Laparoscopy
3.8
17.5
57
163
G54.0
ICD-10 Finland
Brachial plexus disorders
4.6
17.3
42
96
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
17.1
168
869
M54.4
ICD-10 Finland
Lumbago with sciatica
2.4
17.1
150
739
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.7
17.1
56
161
M54.2
ICD-10 Finland
Cervicalgia
3.0
17.0
81
294
U07
ICPC
Urine symptom/complaint other
3.2
17.0
74
255
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
16.8
125
572
Q79.3
ICD-10 Finland
Gastroschisis
+∞
16.7
16
*
N02CC05
ATC
almotriptan; oral
3.6
16.7
58
173
Z02.7
ICD-10 Finland
Issue of medical certificate
3.1
16.7
75
263
J45
ICD-10 Finland
Asthma
2.7
16.7
101
417
J45.1
ICD-10 Finland
Nonallergic asthma
3.2
16.6
69
231
A04
ICPC
Weakness/tiredness general
2.4
16.6
141
685
ZXE00
NOMESCO Finland
One hour or less
2.1
16.6
279
1777
N03AE01
ATC
clonazepam; systemic
3.8
16.5
52
145
J01FF01
ATC
clindamycin; systemic
2.2
16.5
183
994
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.4
16.4
33
64
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
16.3
89
348
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
16.3
166
870
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.3
16.1
159
822
N06AX11
ATC
mirtazapine; oral
2.1
15.9
238
1446
R06AE07
ATC
cetirizine; oral
2.0
15.9
333
2283
XA800
NOMESCO Finland
Neuropsychological investigation
3.6
15.9
55
164
A02BC03
ATC
lansoprazole; oral
2.2
15.8
162
851
R00.2
ICD-10 Finland
Palpitations
2.8
15.7
86
337
Q76.9
ICD-10 Finland
Congenital malformation of bony thorax, unspecified
+∞
15.7
15
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.0
15.7
74
267
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
15.6
166
883
Z71.8
ICD-10 Finland
Other specified counselling
2.0
15.6
284
1847
R96
ICPC
Asthma
2.9
15.6
81
308
R51.81
ICD-10 Finland
Facial pain NOS
5.0
15.6
34
71
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.4
15.6
26
42
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
15.6
307
2055
F45.8
ICD-10 Finland
Other somatoform disorders
2.7
15.5
90
363
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
15.5
65
219
M01AH02
ATC
rofecoxib; oral
3.1
15.4
70
247
R42
ICD-10 Finland
Dizziness and giddiness
2.3
15.3
140
700
N02BE01
ATC
paracetamol; systemic, rectal
3.2
15.2
552
4657
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.6
15.1
53
159
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
15.1
91
374
N06AX22
ATC
agomelatine; oral
4.3
15.1
40
98
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.5
15.1
25
40
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
15.1
86
344
R02
ICPC
Shortness of breath/dyspnoea
2.6
15.0
102
445
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.6
15.0
52
155
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
15.0
209
1233
R5140
NOMESCO Finland
Monitoring the use of the aid
3.0
14.9
72
263
SPAT1216
SPAT
Assessment of functional ability
2.7
14.9
86
346
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.4
14.9
55
171
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
14.8
84
335
UJF92
NOMESCO Finland
Capsular endoscopy
5.5
14.8
29
55
N02CD03
ATC
fremanezumab; systemic
6.3
14.8
25
41
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
14.7
177
986
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
14.7
86
349
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.0
14.6
42
110
R4110, ,
SPAT
2.5
14.5
98
427
J45.8
ICD-10 Finland
Mixed asthma
4.6
14.4
35
80
N02CC03
ATC
zolmitriptan; nasal, oral
2.9
14.4
72
268
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.8
14.4
33
72
R20.2
ICD-10 Finland
Paraesthesia of skin
2.9
14.4
75
286
M03AX01
ATC
botulinum toxin; parenteral
5.5
14.3
28
53
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.7
14.3
84
341
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.7
14.3
87
360
N06AB04
ATC
citalopram; systemic
2.2
14.2
147
770
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.0
14.2
66
236
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
14.1
94
406
F50.9
ICD-10 Finland
Eating disorder, unspecified
6.0
14.1
25
43
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.4
14.1
36
86
N02BF01
ATC
gabapentin; oral
2.7
14.0
84
344
ZX120
NOMESCO Finland
Intravenous
2.9
14.0
70
261
XG466
NOMESCO Finland
Sleep oxymetry
6.2
14.0
24
40
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
13.8
102
463
R53
ICD-10 Finland
Malaise and fatigue
2.0
13.7
199
1183
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.7
13.7
22
34
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
13.6
38
97
A02BA03
ATC
famotidine; systemic
6.1
13.6
24
41
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
13.6
175
996
N05BA01
ATC
diazepam; systemic, rectal
2.5
13.6
91
394
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
13.5
65
237
R52.0
ICD-10 Finland
Acute pain
3.7
13.5
43
121
J01EA01
ATC
trimethoprim; systemic
2.0
13.4
190
1118
L12
ICPC
Hand/finger symptom/complaint
2.1
13.4
154
840
SPAT1284
SPAT
Extensive health certificate
4.6
13.2
32
73
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
13.2
78
317
N04BC09
ATC
rotigotine; transdermal
41.1
13.2
16
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
13.2
115
561
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
13.1
223
1398
N81.6
ICD-10 Finland
Rectocele
3.2
13.1
54
180
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
13.0
76
307
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.2
13.0
129
663
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.0
13.0
37
96
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
23.1
13.0
18
8
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
12.9
108
517
J01FA06
ATC
roxithromycin; oral
1.9
12.9
247
1608
R03BA08
ATC
ciclesonide; inhalant
2.7
12.9
76
309
SAA04
NOMESCO Finland
Special examination of mouth
3.0
12.8
61
221
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
12.7
75
305
SBB10
NOMESCO Finland
Dental impressions
2.4
12.7
92
413
R13
ICD-10 Finland
Dysphagia
3.2
12.7
53
178
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
2.3
12.6
112
549
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.9
12.6
61
223
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
12.6
67
258
C09CA06
ATC
candesartan; oral
2.1
12.5
153
851
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
12.5
52
174
J01MA02
ATC
ciprofloxacin; systemic
1.9
12.5
206
1274
R03BB04
ATC
tiotropium bromide; inhalant
3.2
12.5
51
169
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
12.5
161
914
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
12.4
99
463
R33
ICD-10 Finland
Retention of urine
4.1
12.4
35
90
XQ800
NOMESCO Finland
Prick test
2.6
12.3
79
334
J01AA02
ATC
doxycycline; systemic
2.0
12.3
450
3586
A02BC01
ATC
omeprazole; systemic
2.0
12.2
166
959
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
12.2
97
454
R1250, ,
SPAT
4.1
12.2
34
87
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.6
12.2
73
299
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.6
12.1
41
120
N06AB10
ATC
escitalopram; oral
2.0
12.1
178
1056
M89.0
ICD-10 Finland
Algoneurodystrophy
11.4
12.1
22
20
F84.5
ICD-10 Finland
Asperger syndrome
9.6
12.1
24
26
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
12.1
62
234
A06AD11
ATC
lactulose; oral
2.7
12.0
70
282
A06AC51
ATC
ispaghula, combinations; oral
3.6
12.0
40
116
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.4
12.0
44
136
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.8
11.9
61
230
R5599
NOMESCO Finland
Other rehabilitation service
4.1
11.9
33
84
L02
ICPC
Back symptom/complaint
2.3
11.9
101
486
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
15.0
11.9
19
13
L13
ICPC
Hip symptom/complaint
2.2
11.8
115
585
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
11.8
234
1531
N03AG01
ATC
valproic acid; systemic, rectal
2.9
11.7
57
209
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
11.7
281
1949
AA1AD
NOMESCO Finland
CT of head and brain
2.1
11.7
137
749
P01AB01
ATC
metronidazole; oral, rectal
1.8
11.6
277
1914
R4120, ,
SPAT
9.5
11.6
23
25
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.3
11.6
101
491
R1250
NOMESCO Finland
Evaluation of functional capability
4.5
11.6
28
64
N04BC05
ATC
pramipexole; oral
3.1
11.5
51
177
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.3
11.5
44
140
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
11.5
142
791
L82
ICPC
Congenital anomaly musculoskeletal
122.3
11.5
12
*
TQW40
NOMESCO Finland
Remowal of suture of skin
3.0
11.4
53
189
M01AE02
ATC
naproxen; oral, rectal
1.8
11.4
393
3032
N06BA12
ATC
lisdexamfetamine; oral
4.1
11.3
31
78
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.3
11.3
43
136
JBB01
NOMESCO Finland
Laparoscopic repair of paraoesophageal hernia
35.8
11.3
14
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.6
11.3
38
111
D01
ICPC
Abdominal pain/cramps general
2.1
11.3
123
653
D07AD01
ATC
clobetasol; topical
2.2
11.2
110
560
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
11.2
77
336
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
11.2
98
476
N02CC04
ATC
rizatriptan; oral
2.6
11.2
68
280
SPAT1059
SPAT
Spirometry at the office
3.6
11.2
37
107
X58
ICD-10 Finland
Exposure to other specified factors
2.1
11.1
120
634
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.4
11.1
22
42
ZXA10
NOMESCO Finland
Bilateral
2.2
11.1
110
562
G43
ICD-10 Finland
Migraine
2.4
11.1
80
357
SPAT1231
SPAT
Assessment of adjustments needed in living environment
11.4
11.1
20
18
S83.0
ICD-10 Finland
Dislocation of patella
3.8
11.1
34
93
B02AA02
ATC
tranexamic acid; systemic
2.1
11.1
132
724
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
10.3
11.1
21
21
R03AC13
ATC
formoterol; inhalant
3.7
11.1
35
98
ZXD20
NOMESCO Finland
Day surgery
2.3
11.0
94
452
R03BA05
ATC
fluticasone; inhalant
2.0
11.0
142
803
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
5.5
10.9
21
39
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.9
10.9
32
85
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
10.9
49
172
SPAT1240
SPAT
Therapeutic discussion
2.2
10.8
106
539
M54.1
ICD-10 Finland
Radiculopathy
3.7
10.7
35
100
M02AA07
ATC
piroxicam; topical
1.9
10.7
179
1102
J02AC01
ATC
fluconazole; systemic
1.8
10.7
300
2161
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.1
10.7
125
681
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.4
10.7
27
64
R06AX27
ATC
desloratadine; oral
1.8
10.6
249
1700
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.7
10.6
34
96
R03BA02
ATC
budesonide; inhalant
2.0
10.6
139
788
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
4.1
10.6
29
73
N02CC06
ATC
eletriptan; oral
3.0
10.6
48
169
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
10.6
259
1791
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.0
10.5
49
175
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
14.5
10.5
17
12
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
10.5
92
447
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.3
10.5
40
127
N89
ICPC
Migraine
2.6
10.5
62
252
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.2
10.4
43
143
R06AX22
ATC
ebastine; oral
2.0
10.4
134
754
N06AX12
ATC
bupropion; oral
2.4
10.4
78
355
R10.2
ICD-10 Finland
Pelvic and perineal pain
4.0
10.2
29
75
K30
ICD-10 Finland
Functional dyspepsia
2.2
10.2
89
432
L17
ICPC
Foot/toe symptom/complaint
1.8
10.1
207
1353
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
10.1
77
352
C03CA01
ATC
furosemide; systemic
2.2
10.1
100
510
A04AA01
ATC
ondansetron; systemic, rectal
2.6
10.1
60
244
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
10.1
104
539
N06BA04
ATC
methylphenidate; oral
2.5
10.1
64
269
P29
ICPC
Psychological sympt/compl other
2.2
10.1
91
448
R50.9
ICD-10 Finland
Fever, unspecified
2.0
10.0
116
628
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.5
10.0
35
105
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
40.8
10.0
12
*
R03AC03
ATC
terbutaline; inhalant
2.1
10.0
99
506
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
9.9
83
395
N06AA10
ATC
nortriptyline; systemic
4.4
9.9
25
59
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.8
9.9
51
193
H02AB09
ATC
hydrocortisone; systemic
3.9
9.9
29
77
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.0
9.9
45
159
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
9.9
483
4055
R52.1
ICD-10 Finland
Chronic intractable pain
10.9
9.8
18
17
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
9.8
31
87
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
9.8
57
230
W19
ICD-10 Finland
Unspecified fall
2.4
9.7
68
299
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.5
9.7
34
102
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
9.7
93
468
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.9
9.7
29
78
A03FA02
ATC
cisapride; oral, rectal
3.1
9.7
42
144
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
9.7
44
155
N05CF01
ATC
zopiclone; oral
1.8
9.7
171
1067
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.8
9.7
30
83
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.6
9.6
58
238
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.0
9.6
44
156
N05CD07
ATC
temazepam; oral
2.7
9.6
52
202
R55
ICD-10 Finland
Syncope and collapse
2.5
9.5
62
264
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
9.5
67
296
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.1
9.4
39
130
JBB10
NOMESCO Finland
Repair of congenital diaphragmatic hernia
+∞
9.4
9
*
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.0
9.4
42
147
JG1JB
NOMESCO Finland
Defekography with X-ray
10.9
9.3
17
16
J01MA12
ATC
levofloxacin; systemic
2.1
9.2
92
470
N06AX05
ATC
trazodone; oral
4.0
9.2
26
67
M01AH05
ATC
etoricoxib; oral
1.7
9.2
376
2957
L08
ICPC
Shoulder symptom/complaint
1.9
9.2
142
847
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
7.9
9.2
20
26
ZXA00
NOMESCO Finland
Right side
1.9
9.2
126
723
K59.1
ICD-10 Finland
Functional diarrhoea
2.8
9.2
48
183
M03BX02
ATC
tizanidine; oral
1.7
9.2
387
3070
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
9.1
42
149
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.1
9.1
19
38
XF402
NOMESCO Finland
ECG with work load test
2.8
9.1
45
166
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.9
9.1
20
42
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.9
9.1
20
42
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.7
9.1
16
14
R51
ICD-10 Finland
Headache
2.4
9.1
63
276
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
9.1
44
161
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
9.1
51
202
J98.6
ICD-10 Finland
Disorders of diaphragm
37.3
9.0
11
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
9.0
172
1095
L03
ICPC
Low back symptom/complaint
1.7
9.0
206
1383
N02CC07
ATC
frovatriptan; oral
2.5
8.9
56
234
R03AC12
ATC
salmeterol; inhalant
3.7
8.9
28
78
S06.0
ICD-10 Finland
Concussion
2.2
8.9
81
399
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
8.9
201
1343
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
12.8
8.9
15
12
L07
ICPC
Jaw symptom/complaint
4.6
8.9
21
47
N02BF02
ATC
pregabalin; oral
2.6
8.9
52
210
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.1
8.9
24
60
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
8.8
8.8
18
21
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
8.8
119
678
L15
ICPC
Knee symptom/complaint
1.8
8.8
163
1027
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.9
8.8
43
158
M01AC06
ATC
meloxicam; systemic, rectal
1.8
8.8
191
1262
J01DB01
ATC
cefalexin; oral
2.0
8.8
514
4461
R03BA01
ATC
beclometasone; inhalant
2.1
8.8
88
451
Z01.9
ICD-10 Finland
Special examination, unspecified
2.7
8.7
46
176
Z01.2
ICD-10 Finland
Dental examination
1.7
8.7
343
2654
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
50.7
8.7
10
*
S18
ICPC
Laceration/cut
1.7
8.7
264
1910
L01
ICPC
Neck symptom/complaint
1.9
8.6
126
737
R06.5
ICD-10 Finland
Mouth breathing
2.5
8.6
56
238
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
11.8
8.6
15
13
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.5
8.6
30
90
M22.1
ICD-10 Finland
Recurrent subluxation of patella
10.2
8.6
16
16
M54.3
ICD-10 Finland
Sciatica
3.0
8.5
39
138
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
8.5
312
2364
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
28.0
8.5
11
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
8.5
133
796
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
8.5
29
86
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
6.9
8.4
20
30
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.9
8.4
114
651
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.4
70
333
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.7
8.4
47
186
S03.0
ICD-10 Finland
Dislocation of jaw
8.7
8.3
17
20
G81.9
ICD-10 Finland
Hemiplegia, unspecified
8.7
8.3
17
20
N05CF02
ATC
zolpidem; oral
1.9
8.3
116
667
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.9
8.3
24
63
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
8.3
201
1365
N06AB06
ATC
sertraline; oral
2.0
8.3
104
578
R15
ICD-10 Finland
Faecal incontinence
4.3
8.3
21
50
J01FA10
ATC
azithromycin; systemic
1.7
8.2
409
3340
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
14.7
8.2
13
9
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
14.7
8.2
13
9
SFA10
NOMESCO Finland
One-surface restoration
1.7
8.2
378
3025
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.9
8.2
38
136
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.9
8.2
18
38
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
4.1
8.1
22
55
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.1
8.1
33
109
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.8
8.1
41
154
M23.8
ICD-10 Finland
Other internal derangements of knee
3.1
8.1
34
115
N06AB03
ATC
fluoxetine; oral
2.1
8.0
87
458
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
3.0
8.0
35
121
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
8.0
54
234
M54.8
ICD-10 Finland
Other dorsalgia
2.8
8.0
41
155
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
4.0
7.9
22
56
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
7.9
34
116
C10AC01
ATC
colestyramine; oral
3.6
7.9
26
75
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
7.9
296
2243
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.1
7.9
21
52
M70.6
ICD-10 Finland
Trochanteric bursitis
2.1
7.9
83
433
N02CC02
ATC
naratriptan; oral
3.7
7.8
24
66
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.8
197
1349
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.3
7.8
20
48
R06AE09
ATC
levocetirizine; oral
1.9
7.8
114
666
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.1
7.8
77
392
A03CA02
ATC
clidinium and psycholeptics; oral
3.4
7.7
28
86
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
7.7
32
107
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
4.4
7.7
19
44
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.4
7.7
19
44
120
Kela drug reimbursment
Hypogammaglobulinaemia
45.6
7.7
9
*
R01AD09
ATC
mometasone; nasal
1.6
7.7
312
2402
C05AA08
ATC
fluocortolone; rectal, topical
2.2
7.7
71
351
K80
ICPC
Cardiac arrhythmia NOS
2.4
7.7
56
251
G44.8
ICD-10 Finland
Other specified headache syndromes
4.1
7.7
21
53
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.2
7.7
30
97
J01FA09
ATC
clarithromycin; systemic
1.7
7.7
206
1433
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
7.6
70
346
XCK00
NOMESCO Finland
Perimetry
3.0
7.6
34
119
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
7.6
86
460
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.7
7.6
42
165
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.6
128
781
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
7.6
63
299
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
10.2
7.6
14
14
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
7.6
35
125
Z00.8
ICD-10 Finland
Other general examinations
2.2
7.5
65
313
H02AB04
ATC
methylprednisolone; systemic
2.1
7.5
80
418
B01AB05
ATC
enoxaparin; parenteral
1.7
7.5
156
1012
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
7.5
249
1825
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.5
7.5
18
41
RD210, ,
NOMESCO Finland
3.5
7.5
25
73
D12
ICPC
Constipation
3.4
7.5
26
78
SPAT1210
SPAT
Application of cast or individual aid
3.0
7.4
33
115
Q87.4
ICD-10 Finland
Marfan syndrome
81.1
7.4
8
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.6
7.4
43
173
R03DA04
ATC
theophylline; systemic, rectal
3.8
7.4
22
59
XKC03
NOMESCO Finland
Water cystometry
3.8
7.4
22
59
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.1
7.4
20
50
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.7
7.4
23
64
M53.2
ICD-10 Finland
Spinal instabilities
8.5
7.4
15
18
OAB43, ,
SPAT
0.6
7.3
160
2285
PD5BD
NOMESCO Finland
Extensive CT of aorta
9.5
7.3
14
15
Q79.18
ICD-10 Finland
Other congenital malformations of diaphragm
+∞
7.3
7
*
R07.3
ICD-10 Finland
Other chest pain
2.2
7.3
65
318
D06
ICPC
Abdominal pain localized other
2.1
7.2
74
381
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
16.0
7.2
11
7
N28
ICPC
Limited function/disability (N)
7.4
7.2
16
22
R03AK11
ATC
formoterol and fluticasone; inhalant
4.0
7.2
20
51
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
7.2
351
2808
WX882
NOMESCO Finland
High dependency care
3.5
7.2
24
70
R01AD08
ATC
fluticasone; nasal
1.7
7.2
190
1312
R06AX13
ATC
loratadine; oral
1.8
7.2
116
698
SPAT1260
SPAT
Consultation of another employee
1.9
7.2
101
582
C08CA05
ATC
nifedipine; systemic
3.0
7.2
32
112
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
30.4
7.2
9
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
30.4
7.2
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
7.2
59
279
N01
ICPC
Headache
1.8
7.2
128
794
R5599, ,
SPAT
20.3
7.2
10
5
N05BA04
ATC
oxazepam; oral
1.7
7.1
163
1084
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
7.1
42
171
N02CD02
ATC
galcanezumab; parenteral
8.9
7.1
14
16
R06.4
ICD-10 Finland
Hyperventilation
4.3
7.1
18
43
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.3
7.1
18
43
A01AB09
ATC
miconazole; local oral
2.4
7.1
51
228
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
7.0
96
547
A29
ICPC
General symptom/complaint other
2.0
7.0
82
444
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
3.8
7.0
21
57
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
7.0
351
2821
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
7.0
32
114
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.3
6.9
53
243
F34.1
ICD-10 Finland
Dysthymia
2.7
6.9
38
149
G44
ICD-10 Finland
Other headache syndromes
14.0
6.9
11
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
6.9
39
155
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.9
39
155
E87.6
ICD-10 Finland
Hypokalaemia
3.5
6.9
23
67
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
6.9
147
958
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
4.2
6.9
18
44
H52.1
ICD-10 Finland
Myopia
2.5
6.8
42
174
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.7
6.8
37
144
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.2
6.8
27
88
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
6.8
45
193
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.2
6.8
17
28
N03AF01
ATC
carbamazepine; oral, rectal
2.8
6.8
33
121
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.0
6.8
29
99
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
6.8
51
232
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.5
6.8
43
181
F48.0
ICD-10 Finland
Neurasthenia
40.5
6.8
8
*
SPAT1211
SPAT
Application of soft bandage
2.2
6.8
58
279
WX722
NOMESCO Finland
PEEP
3.4
6.8
24
73
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.0
6.8
19
49
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
7.3
6.7
15
21
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.7
61
300
9243
FHL
Plastic of the patella and its tendons
6.5
6.7
16
25
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.0
6.6
17
29
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
6.6
473
4107
XFE00
NOMESCO Finland
Epicardial ultrasonography
7.9
6.6
14
18
R4130
NOMESCO Finland
Speech therapy
3.5
6.6
22
64
WW200
NOMESCO Finland
Immunization
3.5
6.6
22
64
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
6.6
205
1467
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.4
6.6
23
69
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.5
6.6
41
171
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.2
6.6
17
41
N06AX03
ATC
mianserin; oral
2.9
6.6
31
112
N06AX17
ATC
milnacipran; oral
7.0
6.5
15
22
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.7
6.5
34
130
L18
ICPC
Muscle pain
2.6
6.5
36
142
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
6.5
168
1150
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.5
6.4
14
19
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
70.6
6.4
7
*
RF310, ,
NOMESCO Finland
70.6
6.4
7
*
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.7
6.4
33
125
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
6.4
39
161
R04
ICPC
Breathing problem other
2.9
6.4
30
108
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.7
6.4
34
131
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
6.4
152
1017
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.1
6.4
17
42
SPAT1153
SPAT
Removal of sutures
1.7
6.3
147
977
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
6.3
97
573
U02
ICPC
Urinary frequency/urgency
1.8
6.3
97
573
PD5AD
NOMESCO Finland
CT of aorta
5.6
6.3
17
31
NG2AA
NOMESCO Finland
Patella X-ray examination
3.5
6.3
21
61
M76.0
ICD-10 Finland
Gluteal tendinitis
3.3
6.3
23
71
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
6.3
158
1070
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
6.3
245
1842
P25
ICPC
Phase of life problem adult
2.4
6.3
45
200
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.0
6.3
75
408
K07.61
ICD-10 Finland
Cracking jaw joint
2.9
6.3
28
98
SPAT1263
SPAT
Sampling
1.6
6.3
250
1890
M01AB05
ATC
diclofenac; systemic, rectal
1.6
6.3
366
3008
Q79.5
ICD-10 Finland
Other congenital malformations of abdominal wall
+∞
6.3
6
*
JAG10
NOMESCO Finland
Repair of gastroschisis
+∞
6.3
6
*
JAG20
NOMESCO Finland
Repair of omphalocele
+∞
6.3
6
*
M05BA04
ATC
alendronic acid; oral
2.7
6.3
32
121
SPAT1097
SPAT
Recording of ECG
2.1
6.2
63
323
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.6
6.2
20
57
NA1BG, ,
SPAT
3.3
6.2
23
72
SPAT1312
SPAT
General health counselling
1.6
6.2
211
1539
N30.9
ICD-10 Finland
Cystitis, unspecified
2.2
6.2
52
248
N02CD06
ATC
rimegepant; oral
6.4
6.2
15
24
NGE60
NOMESCO Finland
Plastic repair of patellar ligaments, open
6.4
6.2
15
24
M23.5
ICD-10 Finland
Chronic instability of knee
7.8
6.1
13
17
G43.8
ICD-10 Finland
Other migraine
3.1
6.1
25
83
WZA90
NOMESCO Finland
Other medical or dental certificate
1.6
6.1
162
1113
J01DA01
ATC
[U] cefalexin
1.5
6.1
353
2888
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.1
200
1445
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
6.1
51
243
R60.0
ICD-10 Finland
Localized oedema
2.0
6.1
63
326
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
2.7
6.1
31
117
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.9
6.1
28
100
R06.2
ICD-10 Finland
Wheezing
2.5
6.1
37
153
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.5
6.1
37
153
ZXD35
NOMESCO Finland
Usual procedure
3.3
6.1
22
68
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
6.0
50
237
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
5.3
6.0
17
33
RS222, ,
NOMESCO Finland
5.6
6.0
16
29
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
6.0
49
231
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hypermobility syndrome
M35.7 [45601437]
M35.7 [45601437]
4.3e+00
5.0e+00
—
1.0e+50
4.1e+00
5.0e+00
4.1e+00
cases:12.92%
controls:0.19%
cases:18.02%
controls:0.14%
—
—
cases:3.18%
controls:0.00%
cases:4.96%
controls:0.09%
cases:13.39%
controls:0.11%
cases:15.47%
controls:0.29%
73
11
492
5635
102
8
464
5644
—
18
0
548
5652
28
5
536
5638
73
6
472
5498
73
14
399
4737
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
2.4e+00
2.7e+00
3.0e+00
—
2.9e+00
3.0e+00
2.8e+00
cases:7.08%
controls:0.71%
cases:4.95%
controls:0.35%
cases:1.77%
controls:0.09%
—
—
cases:1.60%
controls:0.09%
cases:6.79%
controls:0.36%
cases:11.02%
controls:0.78%
40
40
525
5606
28
20
538
5632
10
5
556
5647
—
9
5
555
5638
37
20
508
5484
52
37
420
4714
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
1.5e+00
2.4e+00
3.2e+00
1.0e+50
4.0e+00
3.2e+00
2.3e+00
cases:9.38%
controls:2.34%
cases:7.42%
controls:0.69%
cases:3.36%
controls:0.14%
cases:2.30%
controls:0.00%
cases:4.79%
controls:0.09%
cases:8.99%
controls:0.42%
cases:12.29%
controls:1.41%
53
132
512
5514
42
39
524
5613
19
8
547
5644
13
0
553
5652
27
5
537
5638
49
23
496
5481
58
67
414
4684
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
1.8e+00
2.6e+00
2.6e+00
—
3.8e+00
3.2e+00
2.5e+00
cases:28.32%
controls:6.32%
cases:26.33%
controls:2.51%
cases:8.48%
controls:0.67%
—
—
cases:16.49%
controls:0.43%
cases:36.51%
controls:2.40%
cases:45.55%
controls:6.50%
160
357
405
5289
149
142
417
5510
48
38
518
5614
—
93
24
471
5619
199
132
346
5372
215
309
257
4442
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
2.1e+00
2.2e+00
2.3e+00
—
2.8e+00
2.8e+00
2.7e+00
cases:7.96%
controls:1.03%
cases:4.95%
controls:0.58%
cases:1.94%
controls:0.19%
—
—
cases:3.19%
controls:0.19%
cases:8.07%
controls:0.55%
cases:15.47%
controls:1.20%
45
58
520
5588
28
33
538
5619
11
11
555
5641
—
18
11
546
5632
44
30
501
5474
73
57
399
4694
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.3e+00
1.7e+00
2.7e+00
1.0e+50
3.7e+00
2.9e+00
2.1e+00
cases:13.27%
controls:4.18%
cases:8.48%
controls:1.65%
cases:3.71%
controls:0.25%
cases:3.18%
controls:0.00%
cases:4.96%
controls:0.12%
cases:17.61%
controls:1.13%
cases:22.25%
controls:3.28%
75
236
490
5410
48
93
518
5559
21
14
545
5638
18
0
548
5652
28
7
536
5636
96
62
449
5442
105
156
367
4595
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
1.5e+00
1.9e+00
2.9e+00
—
2.9e+00
2.8e+00
2.3e+00
cases:7.43%
controls:1.70%
cases:5.12%
controls:0.78%
cases:1.94%
controls:0.11%
—
—
cases:1.60%
controls:0.09%
cases:10.64%
controls:0.71%
cases:17.16%
controls:2.13%
42
96
523
5550
29
44
537
5608
11
6
555
5646
—
9
5
555
5638
58
39
487
5465
81
101
391
4650
Outpatient Visit
OP [9202]
OP [9202]
8.5e-01
1.2e+00
1.2e+00
5.5e+00
1.6e+00
1.5e+00
1.3e+00
cases:86.19%
controls:72.79%
cases:75.44%
controls:47.59%
cases:27.92%
controls:10.51%
cases:57.42%
controls:0.55%
cases:36.35%
controls:10.14%
cases:80.18%
controls:47.20%
cases:92.58%
controls:77.86%
487
4110
78
1536
427
2690
139
2962
158
594
408
5058
325
31
241
5621
205
572
359
5071
437
2598
108
2906
437
3699
35
1052
Psychiatry
26 [38004469]
26 [38004469]
1.3e+00
1.5e+00
1.7e+00
3.2e+00
1.6e+00
1.7e+00
1.6e+00
cases:24.25%
controls:8.25%
cases:16.78%
controls:4.42%
cases:8.13%
controls:1.63%
cases:2.12%
controls:0.09%
cases:7.80%
controls:1.67%
cases:18.90%
controls:3.92%
cases:30.08%
controls:8.21%
137
466
428
5180
95
250
471
5402
46
92
520
5560
12
5
554
5647
44
94
520
5549
103
216
442
5288
142
390
330
4361
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
1.8e+00
1.9e+00
1.9e+00
—
2.5e+00
2.2e+00
2.0e+00
cases:9.56%
controls:1.77%
cases:7.07%
controls:1.10%
cases:2.30%
controls:0.35%
—
—
cases:3.72%
controls:0.30%
cases:8.44%
controls:0.96%
cases:13.14%
controls:2.10%
54
100
511
5546
40
62
526
5590
13
20
553
5632
—
21
17
543
5626
46
53
499
5451
62
100
410
4651
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
1.7e+00
2.1e+00
2.1e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:9.91%
controls:1.91%
cases:8.66%
controls:1.17%
cases:3.36%
controls:0.41%
—
—
cases:3.37%
controls:0.27%
cases:8.81%
controls:1.29%
cases:14.41%
controls:2.97%
56
108
509
5538
49
66
517
5586
19
23
547
5629
—
19
15
545
5628
48
71
497
5433
68
141
404
4610
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
2.0e+00
2.8e+00
—
1.0e+50
—
4.2e+00
3.2e+00
cases:4.07%
controls:0.57%
cases:3.00%
controls:0.19%
—
—
cases:1.41%
controls:0.00%
—
—
cases:10.09%
controls:0.16%
cases:11.44%
controls:0.53%
23
32
542
5614
17
11
549
5641
—
8
0
558
5652
—
55
9
490
5495
54
25
418
4726
Disturbance of activity and attention
F90.0 [45542870]
F90.0 [45542870]
1.9e+00
2.0e+00
2.5e+00
—
2.2e+00
1.7e+00
1.6e+00
cases:3.72%
controls:0.58%
cases:4.24%
controls:0.58%
cases:1.94%
controls:0.16%
—
—
cases:1.95%
controls:0.23%
cases:3.85%
controls:0.73%
cases:5.93%
controls:1.22%
21
33
544
5613
24
33
542
5619
11
9
555
5643
—
11
13
553
5630
21
40
524
5464
28
58
444
4693
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
1.1e+00
2.0e+00
2.2e+00
—
2.3e+00
2.3e+00
1.6e+00
cases:2.30%
controls:0.74%
cases:2.65%
controls:0.37%
cases:1.06%
controls:0.12%
—
—
cases:1.24%
controls:0.12%
cases:3.67%
controls:0.38%
cases:4.87%
controls:1.03%
13
42
552
5604
15
21
551
5631
6
7
560
5645
—
7
7
557
5636
20
21
525
5483
23
49
449
4702
Infectious Disease
44 [38004484]
44 [38004484]
1.3e+00
2.0e+00
2.4e+00
1.0e+50
2.5e+00
1.5e+00
1.6e+00
cases:6.55%
controls:1.79%
cases:4.42%
controls:0.64%
cases:1.77%
controls:0.16%
cases:2.30%
controls:0.00%
cases:1.24%
controls:0.11%
cases:3.67%
controls:0.84%
cases:9.32%
controls:2.04%
37
101
528
5545
25
36
541
5616
10
9
556
5643
13
0
553
5652
7
6
557
5637
20
46
525
5458
44
97
428
4654
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
1.5e+00
1.8e+00
2.2e+00
—
2.1e+00
2.0e+00
1.5e+00
cases:23.01%
controls:6.09%
cases:12.54%
controls:2.30%
cases:3.71%
controls:0.41%
—
—
cases:4.08%
controls:0.53%
cases:13.21%
controls:1.94%
cases:23.52%
controls:6.19%
130
344
435
5302
71
130
495
5522
21
23
545
5629
—
23
30
541
5613
72
107
473
5397
111
294
361
4457
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
OMOP4822000 [32411]
1.5e+00
3.4e+00
—
1.0e+50
—
3.7e+00
2.6e+00
cases:5.49%
controls:1.22%
cases:9.19%
controls:0.34%
—
—
cases:16.43%
controls:0.00%
—
—
cases:13.76%
controls:0.40%
cases:11.44%
controls:0.99%
31
69
534
5577
52
19
514
5633
—
93
0
473
5652
—
75
22
470
5482
54
47
418
4704
lisdexamfetamine; oral
N06BA12 [40252237]
N06BA12 [40252237]
2.8e+00
2.2e+00
—
—
2.3e+00
2.0e+00
1.7e+00
cases:1.77%
controls:0.11%
cases:1.41%
controls:0.16%
—
—
—
—
cases:1.42%
controls:0.14%
cases:1.65%
controls:0.24%
cases:2.12%
controls:0.40%
10
6
555
5640
8
9
558
5643
—
—
8
8
556
5635
9
13
536
5491
10
19
462
4732
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
1.6e+00
1.7e+00
1.8e+00
—
1.9e+00
2.0e+00
1.6e+00
cases:14.87%
controls:3.42%
cases:8.13%
controls:1.56%
cases:2.65%
controls:0.46%
—
—
cases:4.43%
controls:0.69%
cases:10.28%
controls:1.49%
cases:15.04%
controls:3.30%
84
193
481
5453
46
88
520
5564
15
26
551
5626
—
25
39
539
5604
56
82
489
5422
71
157
401
4594
baclofen; oral, parenteral
M03BX01 [21604115]
M03BX01 [21604115]
1.8e+00
2.3e+00
—
—
—
2.8e+00
3.7e+00
cases:1.77%
controls:0.30%
cases:1.41%
controls:0.14%
—
—
—
—
—
—
cases:1.83%
controls:0.11%
cases:5.51%
controls:0.15%
10
17
555
5629
8
8
558
5644
—
—
—
10
6
535
5498
26
7
446
4744
Genetic counselling
Z31.5 [45590715]
Z31.5 [45590715]
1.1e+00
3.4e+00
—
1.0e+50
—
3.6e+00
2.4e+00
cases:3.36%
controls:1.10%
cases:8.13%
controls:0.30%
—
—
cases:9.89%
controls:0.00%
—
—
cases:10.28%
controls:0.33%
cases:8.90%
controls:0.86%
19
62
546
5584
46
17
520
5635
—
56
0
510
5652
—
56
18
489
5486
42
41
430
4710
Neurology
13 [38004458]
13 [38004458]
1.3e+00
1.7e+00
1.3e+00
—
2.2e+00
2.0e+00
1.7e+00
cases:25.31%
controls:8.24%
cases:16.96%
controls:3.52%
cases:3.00%
controls:0.81%
—
—
cases:5.14%
controls:0.62%
cases:19.63%
controls:3.31%
cases:32.84%
controls:8.00%
143
465
422
5181
96
199
470
5453
17
46
549
5606
—
29
35
535
5608
107
182
438
5322
155
380
317
4371
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
1.3e+00
2.9e+00
—
1.0e+50
1.0e+50
3.8e+00
2.2e+00
cases:2.30%
controls:0.66%
cases:3.00%
controls:0.18%
—
—
cases:4.59%
controls:0.00%
cases:2.66%
controls:0.00%
cases:5.87%
controls:0.15%
cases:3.60%
controls:0.42%
13
37
552
5609
17
10
549
5642
—
26
0
540
5652
15
0
549
5643
32
8
513
5496
17
20
455
4731
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.0e+00
1.6e+00
9.6e-01
1.5e+00
1.1e+00
1.3e+00
1.4e+00
cases:99.29%
controls:95.11%
cases:96.11%
controls:82.93%
cases:64.13%
controls:40.57%
cases:7.77%
controls:1.80%
cases:66.31%
controls:38.86%
cases:94.86%
controls:83.32%
cases:98.94%
controls:95.92%
561
5370
4
276
544
4687
22
965
363
2293
203
3359
44
102
522
5550
374
2193
190
3450
517
4586
28
918
467
4557
5
194
Other chronic pain
R52.2 [45568139]
R52.2 [45568139]
1.8e+00
2.1e+00
—
—
—
2.8e+00
3.1e+00
cases:1.77%
controls:0.30%
cases:1.24%
controls:0.16%
—
—
—
—
—
—
cases:2.02%
controls:0.13%
cases:5.72%
controls:0.27%
10
17
555
5629
7
9
559
5643
—
—
—
11
7
534
5497
27
13
445
4738
Recurrent dislocation of patella
M22.0 [45538710]
M22.0 [45538710]
2.5e+00
2.3e+00
—
—
—
2.1e+00
2.7e+00
cases:2.30%
controls:0.19%
cases:1.06%
controls:0.11%
—
—
—
—
—
—
cases:1.28%
controls:0.16%
cases:2.12%
controls:0.15%
13
11
552
5635
6
6
560
5646
—
—
—
7
9
538
5495
10
7
462
4744
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
9.3e-01
1.2e+00
2.3e+00
1.0e+50
2.5e+00
1.2e+00
1.3e+00
cases:13.10%
controls:5.61%
cases:6.01%
controls:1.91%
cases:1.06%
controls:0.11%
cases:1.24%
controls:0.00%
cases:1.95%
controls:0.16%
cases:5.50%
controls:1.71%
cases:18.01%
controls:5.64%
74
317
491
5329
34
108
532
5544
6
6
560
5646
7
0
559
5652
11
9
553
5634
30
94
515
5410
85
268
387
4483
Persistent somatoform pain disorder
F45.4 [45605498]
F45.4 [45605498]
3.2e+00
3.3e+00
—
—
1.0e+50
—
2.9e+00
cases:3.01%
controls:0.12%
cases:2.30%
controls:0.09%
—
—
—
—
cases:1.06%
controls:0.00%
—
—
cases:4.45%
controls:0.25%
17
7
548
5639
13
5
553
5647
—
—
6
0
558
5643
—
21
12
451
4739
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.7e+00
1.8e+00
1.8e+00
—
1.8e+00
2.0e+00
1.9e+00
cases:4.78%
controls:0.87%
cases:3.18%
controls:0.53%
cases:0.88%
controls:0.14%
—
—
cases:1.77%
controls:0.28%
cases:4.22%
controls:0.60%
cases:8.69%
controls:1.35%
27
49
538
5597
18
30
548
5622
5
8
561
5644
—
10
16
554
5627
23
33
522
5471
41
64
431
4687
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.0e+00
1.3e+00
2.0e+00
1.0e+50
2.1e+00
1.9e+00
1.1e+00
cases:21.77%
controls:8.93%
cases:9.19%
controls:2.81%
cases:2.12%
controls:0.30%
cases:2.30%
controls:0.00%
cases:3.01%
controls:0.39%
cases:13.58%
controls:2.29%
cases:17.80%
controls:6.82%
123
504
442
5142
52
159
514
5493
12
17
554
5635
13
0
553
5652
17
22
547
5621
74
126
471
5378
84
324
388
4427
Assessment of need for aid
SPAT1229 [2001700330]
SPAT1229 [2001700330]
1.3e+00
2.5e+00
—
—
—
2.7e+00
2.6e+00
cases:2.65%
controls:0.73%
cases:1.77%
controls:0.14%
—
—
—
—
—
—
cases:3.30%
controls:0.24%
cases:7.20%
controls:0.55%
15
41
550
5605
10
8
556
5644
—
—
—
18
13
527
5491
34
26
438
4725
Fibromyalgia
M79.7 [45553272]
M79.7 [45553272]
2.1e+00
2.3e+00
—
1.0e+50
—
2.2e+00
2.5e+00
cases:3.89%
controls:0.50%
cases:2.83%
controls:0.28%
—
—
cases:2.30%
controls:0.00%
—
—
cases:3.12%
controls:0.35%
cases:6.78%
controls:0.61%
22
28
543
5618
16
16
550
5636
—
13
0
553
5652
—
17
19
528
5485
32
29
440
4722
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
1.3e+00
2.8e+00
—
1.0e+50
—
3.0e+00
2.0e+00
cases:2.12%
controls:0.60%
cases:3.18%
controls:0.19%
—
—
cases:1.77%
controls:0.00%
—
—
cases:3.12%
controls:0.16%
cases:3.60%
controls:0.48%
12
34
553
5612
18
11
548
5641
—
10
0
556
5652
—
17
9
528
5495
17
23
455
4728
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
1.5e+00
2.6e+00
—
—
—
2.9e+00
2.2e+00
cases:3.72%
controls:0.89%
cases:2.47%
controls:0.19%
—
—
—
—
—
—
cases:3.12%
controls:0.18%
cases:5.51%
controls:0.65%
21
50
544
5596
14
11
552
5641
—
—
—
17
10
528
5494
26
31
446
4720
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
1.0e+00
1.1e+00
1.8e+00
1.0e+50
1.9e+00
1.7e+00
1.4e+00
cases:7.61%
controls:2.92%
cases:4.42%
controls:1.50%
cases:1.41%
controls:0.23%
cases:2.83%
controls:0.00%
cases:2.30%
controls:0.35%
cases:6.79%
controls:1.33%
cases:14.62%
controls:3.87%
43
165
522
5481
25
85
541
5567
8
13
558
5639
16
0
550
5652
13
20
551
5623
37
73
508
5431
69
184
403
4567
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
1.1e+00
1.6e+00
—
—
2.5e+00
2.0e+00
1.7e+00
cases:13.63%
controls:4.76%
cases:5.83%
controls:1.26%
—
—
—
—
cases:1.24%
controls:0.11%
cases:6.61%
controls:0.94%
cases:13.98%
controls:2.76%
77
269
488
5377
33
71
533
5581
—
—
7
6
557
5637
36
52
509
5452
66
131
406
4620
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
1.1e+00
1.3e+00
1.7e+00
—
2.0e+00
1.6e+00
1.3e+00
cases:18.05%
controls:6.96%
cases:9.54%
controls:2.80%
cases:2.30%
controls:0.44%
—
—
cases:3.55%
controls:0.51%
cases:11.93%
controls:2.60%
cases:22.67%
controls:7.58%
102
393
463
5253
54
158
512
5494
13
25
553
5627
—
20
29
544
5614
65
143
480
5361
107
360
365
4391
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
1.0e+00
1.5e+00
2.0e+00
1.0e+50
2.1e+00
1.2e+00
1.1e+00
cases:14.51%
controls:5.83%
cases:9.72%
controls:2.37%
cases:2.12%
controls:0.28%
cases:0.88%
controls:0.00%
cases:2.30%
controls:0.30%
cases:8.81%
controls:2.93%
cases:22.67%
controls:8.67%
82
329
483
5317
55
134
511
5518
12
16
554
5636
5
0
561
5652
13
17
551
5626
48
161
497
5343
107
412
365
4339
Hospital outpatient
ZY010 [2001311599]
ZY010 [2001311599]
1.1e+00
1.6e+00
—
—
2.1e+00
1.9e+00
2.2e+00
cases:3.72%
controls:1.22%
cases:1.77%
controls:0.37%
—
—
—
—
cases:1.24%
controls:0.16%
cases:2.02%
controls:0.31%
cases:6.99%
controls:0.84%
21
69
544
5577
10
21
556
5631
—
—
7
9
557
5634
11
17
534
5487
33
40
439
4711
Rheumatism, unspecified
M79.0 [45567658]
M79.0 [45567658]
2.4e+00
3.6e+00
—
1.0e+50
—
1.0e+50
2.8e+00
cases:3.89%
controls:0.35%
cases:3.00%
controls:0.09%
—
—
cases:1.41%
controls:0.00%
—
—
cases:1.83%
controls:0.00%
cases:4.03%
controls:0.25%
22
20
543
5626
17
5
549
5647
—
8
0
558
5652
—
10
0
535
5504
19
12
453
4739
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
1.3e+00
1.6e+00
1.7e+00
—
1.4e+00
1.6e+00
1.3e+00
cases:7.26%
controls:2.18%
cases:6.36%
controls:1.42%
cases:1.77%
controls:0.34%
—
—
cases:2.13%
controls:0.53%
cases:5.87%
controls:1.27%
cases:8.05%
controls:2.40%
41
123
524
5523
36
80
530
5572
10
19
556
5633
—
12
30
552
5613
32
70
513
5434
38
114
434
4637
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
1.1e+00
1.4e+00
1.7e+00
—
1.9e+00
1.4e+00
1.1e+00
cases:30.97%
controls:13.46%
cases:17.31%
controls:4.99%
cases:5.30%
controls:1.06%
—
—
cases:4.79%
controls:0.73%
cases:17.06%
controls:4.71%
cases:33.05%
controls:14.08%
175
760
390
4886
98
282
468
5370
30
60
536
5592
—
27
41
537
5602
93
259
452
5245
156
669
316
4082
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
1.2e+00
2.4e+00
—
—
—
2.3e+00
2.5e+00
cases:2.83%
controls:0.85%
cases:1.41%
controls:0.12%
—
—
—
—
—
—
cases:1.83%
controls:0.18%
cases:4.87%
controls:0.40%
16
48
549
5598
8
7
558
5645
—
—
—
10
10
535
5494
23
19
449
4732
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
1.4e+00
1.4e+00
1.5e+00
—
1.5e+00
1.5e+00
1.3e+00
cases:14.69%
controls:4.16%
cases:9.54%
controls:2.51%
cases:2.65%
controls:0.60%
—
—
cases:2.66%
controls:0.58%
cases:8.62%
controls:2.16%
cases:16.10%
controls:5.20%
83
235
482
5411
54
142
512
5510
15
34
551
5618
—
15
33
549
5610
47
119
498
5385
76
247
396
4504
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
9.0e-01
1.7e+00
1.7e+00
1.0e+50
2.4e+00
1.9e+00
1.6e+00
cases:13.98%
controls:6.22%
cases:8.48%
controls:1.70%
cases:1.06%
controls:0.19%
cases:2.12%
controls:0.00%
cases:1.77%
controls:0.16%
cases:8.62%
controls:1.44%
cases:14.19%
controls:3.12%
79
351
486
5295
48
96
518
5556
6
11
560
5641
12
0
554
5652
10
9
554
5634
47
79
498
5425
67
148
405
4603
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.1e+00
1.5e+00
2.4e+00
—
1.7e+00
2.0e+00
1.3e+00
cases:3.54%
controls:1.26%
cases:3.00%
controls:0.65%
cases:1.59%
controls:0.14%
—
—
cases:0.89%
controls:0.16%
cases:3.67%
controls:0.49%
cases:6.14%
controls:1.68%
20
71
545
5575
17
37
549
5615
9
8
557
5644
—
5
9
559
5634
20
27
525
5477
29
80
443
4671
Other specified intervertebral disc degeneration
M51.3 [45591865]
M51.3 [45591865]
1.5e+00
2.1e+00
—
1.0e+50
—
2.6e+00
2.1e+00
cases:3.19%
controls:0.74%
cases:2.65%
controls:0.32%
—
—
cases:1.06%
controls:0.00%
—
—
cases:2.75%
controls:0.20%
cases:5.93%
controls:0.78%
18
42
547
5604
15
18
551
5634
—
6
0
560
5652
—
15
11
530
5493
28
37
444
4714
Asperger syndrome
F84.5 [45576562]
F84.5 [45576562]
2.6e+00
—
—
—
—
2.7e+00
2.9e+00
cases:1.24%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.11%
cases:2.54%
controls:0.15%
7
5
558
5641
—
—
—
—
9
6
536
5498
12
7
460
4744
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
1.4e+00
1.6e+00
—
—
2.1e+00
1.7e+00
1.5e+00
cases:8.14%
controls:2.21%
cases:4.42%
controls:0.96%
—
—
—
—
cases:1.24%
controls:0.16%
cases:5.14%
controls:0.94%
cases:8.69%
controls:2.10%
46
125
519
5521
25
54
541
5598
—
—
7
9
557
5634
28
52
517
5452
41
100
431
4651
Orthopedic Surgery
20 [38004465]
20 [38004465]
1.2e+00
1.5e+00
1.5e+00
—
1.5e+00
1.4e+00
1.1e+00
cases:29.73%
controls:11.18%
cases:16.96%
controls:4.51%
cases:3.36%
controls:0.78%
—
—
cases:2.48%
controls:0.58%
cases:15.78%
controls:4.34%
cases:30.51%
controls:13.11%
168
631
397
5015
96
255
470
5397
19
44
547
5608
—
14
33
550
5610
86
239
459
5265
144
623
328
4128
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.5e+00
1.8e+00
—
—
2.2e+00
1.6e+00
9.9e-01
cases:5.13%
controls:1.17%
cases:2.47%
controls:0.42%
—
—
—
—
cases:1.24%
controls:0.14%
cases:2.20%
controls:0.45%
cases:4.45%
controls:1.70%
29
66
536
5580
14
24
552
5628
—
—
7
8
557
5635
12
25
533
5479
21
81
451
4670
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
9.7e-01
1.4e+00
1.4e+00
—
1.8e+00
1.3e+00
1.3e+00
cases:17.70%
controls:7.56%
cases:12.19%
controls:3.41%
cases:3.18%
controls:0.83%
—
—
cases:3.01%
controls:0.50%
cases:11.74%
controls:3.65%
cases:22.46%
controls:7.45%
100
427
465
5219
69
193
497
5459
18
47
548
5605
—
17
28
547
5615
64
201
481
5303
106
354
366
4397
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
1.4e+00
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:2.30%
controls:0.60%
cases:1.59%
controls:0.21%
—
—
—
—
—
—
cases:2.75%
controls:0.24%
cases:5.93%
controls:0.69%
13
34
552
5612
9
12
557
5640
—
—
—
15
13
530
5491
28
33
444
4718
Snapping jaw
K07.60 [2000502791]
K07.60 [2000502791]
1.3e+00
1.9e+00
—
—
—
2.6e+00
2.3e+00
cases:3.36%
controls:0.97%
cases:2.30%
controls:0.35%
—
—
—
—
—
—
cases:4.04%
controls:0.33%
cases:9.75%
controls:1.07%
19
55
546
5591
13
20
553
5632
—
—
—
22
18
523
5486
46
51
426
4700
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
1.3e+00
2.0e+00
—
—
—
2.7e+00
2.1e+00
cases:5.84%
controls:1.72%
cases:3.89%
controls:0.57%
—
—
—
—
—
—
cases:6.61%
controls:0.49%
cases:12.08%
controls:1.70%
33
97
532
5549
22
32
544
5620
—
—
—
36
27
509
5477
57
81
415
4670
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
NA3AA [2001307026]
1.4e+00
2.4e+00
—
—
—
2.3e+00
1.9e+00
cases:3.36%
controls:0.87%
cases:2.12%
controls:0.19%
—
—
—
—
—
—
cases:2.20%
controls:0.24%
cases:4.87%
controls:0.76%
19
49
546
5597
12
11
554
5641
—
—
—
12
13
533
5491
23
36
449
4715
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
1.2e+00
1.2e+00
1.6e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:10.44%
controls:3.37%
cases:6.36%
controls:1.96%
cases:1.77%
controls:0.37%
—
—
cases:1.95%
controls:0.44%
cases:5.69%
controls:1.82%
cases:11.44%
controls:3.60%
59
190
506
5456
36
111
530
5541
10
21
556
5631
—
11
25
553
5618
31
100
514
5404
54
171
418
4580
epinephrine
S01EA01 [21603673]
S01EA01 [21603673]
1.8e+00
2.0e+00
—
—
—
1.9e+00
2.1e+00
cases:8.85%
controls:1.56%
cases:4.42%
controls:0.62%
—
—
—
—
—
—
cases:5.50%
controls:0.87%
cases:11.86%
controls:1.64%
50
88
515
5558
25
35
541
5617
—
—
—
30
48
515
5456
56
78
416
4673
epinephrine; parenteral
C01CA24 [21600303]
C01CA24 [21600303]
1.8e+00
2.0e+00
—
—
—
1.9e+00
2.1e+00
cases:8.85%
controls:1.56%
cases:4.42%
controls:0.62%
—
—
—
—
—
—
cases:5.50%
controls:0.87%
cases:11.86%
controls:1.64%
50
88
515
5558
25
35
541
5617
—
—
—
30
48
515
5456
56
78
416
4673
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
NA3BG [2001307034]
1.1e+00
2.4e+00
—
—
—
2.3e+00
1.9e+00
cases:3.36%
controls:1.10%
cases:2.65%
controls:0.25%
—
—
—
—
—
—
cases:2.94%
controls:0.29%
cases:6.99%
controls:1.09%
19
62
546
5584
15
14
551
5638
—
—
—
16
16
529
5488
33
52
439
4699
General Surgery
2 [38004447]
2 [38004447]
9.7e-01
1.2e+00
1.7e+00
1.0e+50
1.4e+00
1.4e+00
1.0e+00
cases:26.90%
controls:12.22%
cases:10.60%
controls:3.29%
cases:2.65%
controls:0.48%
cases:4.06%
controls:0.00%
cases:2.66%
controls:0.67%
cases:11.38%
controls:3.02%
cases:22.67%
controls:9.68%
152
690
413
4956
60
186
506
5466
15
27
551
5625
23
0
543
5652
15
38
549
5605
62
166
483
5338
107
460
365
4291
Other spondylosis with radiculopathy
M47.2 [45591850]
M47.2 [45591850]
1.6e+00
2.0e+00
—
—
—
2.4e+00
1.8e+00
cases:1.95%
controls:0.41%
cases:1.41%
controls:0.19%
—
—
—
—
—
—
cases:2.57%
controls:0.24%
cases:2.54%
controls:0.44%
11
23
554
5623
8
11
558
5641
—
—
—
14
13
531
5491
12
21
460
4730
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.2e+00
1.8e+00
—
—
—
2.7e+00
2.1e+00
cases:4.96%
controls:1.61%
cases:2.65%
controls:0.44%
—
—
—
—
—
—
cases:3.85%
controls:0.27%
cases:6.36%
controls:0.86%
28
91
537
5555
15
25
551
5627
—
—
—
21
15
524
5489
30
41
442
4710
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.2e+00
1.8e+00
—
—
—
2.7e+00
2.1e+00
cases:4.96%
controls:1.61%
cases:2.65%
controls:0.44%
—
—
—
—
—
—
cases:3.85%
controls:0.27%
cases:6.36%
controls:0.86%
28
91
537
5555
15
25
551
5627
—
—
—
21
15
524
5489
30
41
442
4710
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.2e+00
1.8e+00
—
—
—
2.7e+00
2.1e+00
cases:4.96%
controls:1.61%
cases:2.65%
controls:0.44%
—
—
—
—
—
—
cases:3.85%
controls:0.27%
cases:6.36%
controls:0.86%
28
91
537
5555
15
25
551
5627
—
—
—
21
15
524
5489
30
41
442
4710
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.2e+00
1.8e+00
—
—
—
2.7e+00
2.1e+00
cases:4.96%
controls:1.61%
cases:2.65%
controls:0.44%
—
—
—
—
—
—
cases:3.85%
controls:0.27%
cases:6.36%
controls:0.86%
28
91
537
5555
15
25
551
5627
—
—
—
21
15
524
5489
30
41
442
4710
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.2e+00
1.8e+00
—
—
—
2.7e+00
2.1e+00
cases:4.96%
controls:1.61%
cases:2.65%
controls:0.44%
—
—
—
—
—
—
cases:3.85%
controls:0.27%
cases:6.36%
controls:0.86%
28
91
537
5555
15
25
551
5627
—
—
—
21
15
524
5489
30
41
442
4710
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
4.3e-01
7.1e-01
1.4e+00
2.5e+00
1.1e+00
8.6e-01
7.1e-01
cases:36.46%
controls:27.24%
cases:30.21%
controls:17.50%
cases:11.31%
controls:3.01%
cases:2.83%
controls:0.25%
cases:9.04%
controls:3.26%
cases:33.94%
controls:17.86%
cases:61.23%
controls:43.80%
206
1538
359
4108
171
989
395
4663
64
170
502
5482
16
14
550
5638
51
184
513
5459
185
983
360
4521
289
2081
183
2670
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
1.1e+00
1.2e+00
2.0e+00
1.0e+50
2.5e+00
1.4e+00
1.4e+00
cases:5.66%
controls:2.00%
cases:2.47%
controls:0.76%
cases:0.88%
controls:0.12%
cases:1.06%
controls:0.00%
cases:1.24%
controls:0.11%
cases:3.30%
controls:0.80%
cases:8.47%
controls:2.17%
32
113
533
5533
14
43
552
5609
5
7
561
5645
6
0
560
5652
7
6
557
5637
18
44
527
5460
40
103
432
4648
Other rehabilitation service
R5599 [2001310270]
R5599 [2001310270]
2.3e+00
2.5e+00
—
1.0e+50
—
2.7e+00
1.8e+00
cases:1.42%
controls:0.14%
cases:1.06%
controls:0.09%
—
—
cases:1.06%
controls:0.00%
—
—
cases:1.28%
controls:0.09%
cases:1.27%
controls:0.21%
8
8
557
5638
6
5
560
5647
—
6
0
560
5652
—
7
5
538
5499
6
10
466
4741
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
1.0e+00
1.3e+00
2.2e+00
—
—
1.8e+00
1.2e+00
cases:8.14%
controls:3.15%
cases:3.53%
controls:0.96%
cases:1.06%
controls:0.12%
—
—
—
—
cases:4.04%
controls:0.69%
cases:10.38%
controls:3.49%
46
178
519
5468
20
54
546
5598
6
7
560
5645
—
—
22
38
523
5466
49
166
423
4585
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
4.7e-01
7.1e-01
1.2e+00
2.3e+00
1.3e+00
7.4e-01
7.3e-01
cases:35.58%
controls:25.70%
cases:31.10%
controls:18.14%
cases:10.25%
controls:3.29%
cases:2.83%
controls:0.30%
cases:10.46%
controls:3.03%
cases:33.21%
controls:19.15%
cases:60.59%
controls:42.58%
201
1451
364
4195
176
1025
390
4627
58
186
508
5466
16
17
550
5635
59
171
505
5472
181
1054
364
4450
286
2023
186
2728
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
1.5e+00
1.9e+00
2.3e+00
—
—
2.3e+00
1.7e+00
cases:3.36%
controls:0.76%
cases:2.65%
controls:0.39%
cases:0.88%
controls:0.09%
—
—
—
—
cases:3.12%
controls:0.31%
cases:4.24%
controls:0.84%
19
43
546
5603
15
22
551
5630
5
5
561
5647
—
—
17
17
528
5487
20
40
452
4711
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
1.5e+00
1.8e+00
1.4e+00
—
1.5e+00
1.4e+00
1.1e+00
cases:18.23%
controls:4.71%
cases:9.19%
controls:1.65%
cases:1.24%
controls:0.30%
—
—
cases:2.13%
controls:0.46%
cases:8.26%
controls:2.07%
cases:16.95%
controls:6.59%
103
266
462
5380
52
93
514
5559
7
17
559
5635
—
12
26
552
5617
45
114
500
5390
80
313
392
4438
Urology
34 [38004474]
34 [38004474]
1.1e+00
1.2e+00
1.2e+00
—
2.3e+00
1.3e+00
1.5e+00
cases:6.19%
controls:2.11%
cases:2.83%
controls:0.90%
cases:0.88%
controls:0.27%
—
—
cases:1.24%
controls:0.12%
cases:3.49%
controls:0.98%
cases:9.32%
controls:2.32%
35
119
530
5527
16
51
550
5601
5
15
561
5637
—
7
7
557
5636
19
54
526
5450
44
110
428
4641
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.1e+00
1.7e+00
—
—
—
2.6e+00
2.0e+00
cases:4.96%
controls:1.79%
cases:2.83%
controls:0.51%
—
—
—
—
—
—
cases:4.22%
controls:0.33%
cases:6.57%
controls:0.97%
28
101
537
5545
16
29
550
5623
—
—
—
23
18
522
5486
31
46
441
4705
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.1e+00
1.7e+00
—
—
—
2.6e+00
2.0e+00
cases:4.96%
controls:1.79%
cases:2.83%
controls:0.51%
—
—
—
—
—
—
cases:4.22%
controls:0.33%
cases:6.57%
controls:0.97%
28
101
537
5545
16
29
550
5623
—
—
—
23
18
522
5486
31
46
441
4705
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.1e+00
1.7e+00
—
—
—
2.6e+00
2.0e+00
cases:4.96%
controls:1.79%
cases:2.83%
controls:0.51%
—
—
—
—
—
—
cases:4.22%
controls:0.33%
cases:6.57%
controls:0.97%
28
101
537
5545
16
29
550
5623
—
—
—
23
18
522
5486
31
46
441
4705
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
4.7e-01
7.1e-01
1.2e+00
2.2e+00
1.3e+00
7.4e-01
7.3e-01
cases:35.58%
controls:25.66%
cases:30.92%
controls:18.03%
cases:9.89%
controls:3.24%
cases:2.65%
controls:0.30%
cases:10.11%
controls:2.99%
cases:33.03%
controls:19.02%
cases:60.59%
controls:42.48%
201
1449
364
4197
175
1019
391
4633
56
183
510
5469
15
17
551
5635
57
169
507
5474
180
1047
365
4457
286
2018
186
2733
Hand Surgery
40 [38004480]
40 [38004480]
1.1e+00
1.4e+00
—
—
1.6e+00
1.8e+00
1.4e+00
cases:7.61%
controls:2.73%
cases:4.42%
controls:1.13%
—
—
—
—
cases:1.42%
controls:0.28%
cases:5.32%
controls:0.96%
cases:11.23%
controls:2.88%
43
154
522
5492
25
64
541
5588
—
—
8
16
556
5627
29
53
516
5451
53
137
419
4614
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
1.5e+00
1.7e+00
—
—
—
2.3e+00
1.6e+00
cases:3.36%
controls:0.80%
cases:1.94%
controls:0.35%
—
—
—
—
—
—
cases:3.12%
controls:0.31%
cases:4.03%
controls:0.80%
19
45
546
5601
11
20
555
5632
—
—
—
17
17
528
5487
19
38
453
4713
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
2.1e+00
2.3e+00
—
—
—
—
2.8e+00
cases:3.01%
controls:0.39%
cases:1.77%
controls:0.18%
—
—
—
—
—
—
—
—
cases:5.08%
controls:0.34%
17
22
548
5624
10
10
556
5642
—
—
—
—
24
16
448
4735
Voluntary or Charitable Agency
251V00000X [38004202]
251V00000X [38004202]
2.2e+00
—
—
—
—
2.5e+00
2.5e+00
cases:1.24%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.13%
cases:2.97%
controls:0.25%
7
8
558
5638
—
—
—
—
8
7
537
5497
14
12
458
4739
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
8.6e-01
1.4e+00
2.1e+00
1.0e+50
1.0e+00
1.4e+00
1.3e+00
cases:14.69%
controls:6.82%
cases:6.71%
controls:1.73%
cases:1.77%
controls:0.21%
cases:0.88%
controls:0.00%
cases:0.89%
controls:0.32%
cases:6.79%
controls:1.80%
cases:21.40%
controls:6.61%
83
385
482
5261
38
98
528
5554
10
12
556
5640
5
0
561
5652
5
18
559
5625
37
99
508
5405
101
314
371
4437
Cardiology
6 [38004451]
6 [38004451]
5.8e-01
9.0e-01
6.6e-01
—
1.9e+00
2.2e+00
1.5e+00
cases:9.91%
controls:5.79%
cases:6.01%
controls:2.53%
cases:1.06%
controls:0.55%
—
—
cases:1.95%
controls:0.30%
cases:18.53%
controls:2.47%
cases:25.21%
controls:6.74%
56
327
509
5319
34
143
532
5509
6
31
560
5621
—
11
17
553
5626
101
136
444
5368
119
320
353
4431
Retention of urine
R33 [45587507]
R33 [45587507]
1.9e+00
2.5e+00
—
—
—
2.0e+00
2.6e+00
cases:2.30%
controls:0.34%
cases:1.06%
controls:0.09%
—
—
—
—
—
—
cases:0.92%
controls:0.13%
cases:2.33%
controls:0.17%
13
19
552
5627
6
5
560
5647
—
—
—
5
7
540
5497
11
8
461
4743
Pulmonary Disease
29 [38004472]
29 [38004472]
9.5e-01
1.4e+00
1.2e+00
—
1.6e+00
1.5e+00
1.5e+00
cases:13.81%
controls:5.81%
cases:10.78%
controls:2.85%
cases:1.77%
controls:0.51%
—
—
cases:3.01%
controls:0.60%
cases:11.74%
controls:2.80%
cases:23.52%
controls:6.23%
78
328
487
5318
61
161
505
5491
10
29
556
5623
—
17
34
547
5609
64
154
481
5350
111
296
361
4455
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
1.5e+00
2.0e+00
—
—
—
2.6e+00
2.3e+00
cases:1.24%
controls:0.28%
cases:1.06%
controls:0.14%
—
—
—
—
—
—
cases:2.02%
controls:0.15%
cases:4.45%
controls:0.44%
7
16
558
5630
6
8
560
5644
—
—
—
11
8
534
5496
21
21
451
4730
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
1.0e+00
1.0e+00
1.3e+00
—
1.4e+00
1.1e+00
1.1e+00
cases:58.41%
controls:33.14%
cases:36.93%
controls:17.20%
cases:9.01%
controls:2.58%
—
—
cases:9.75%
controls:2.64%
cases:38.35%
controls:16.70%
cases:66.74%
controls:40.20%
330
1871
235
3775
209
972
357
4680
51
146
515
5506
—
55
149
509
5494
209
919
336
4585
315
1910
157
2841
Emergency Room Visit
ER [9203]
ER [9203]
8.6e-01
1.2e+00
1.6e+00
—
1.3e+00
1.0e+00
9.4e-01
cases:54.51%
controls:33.72%
cases:28.45%
controls:10.72%
cases:5.65%
controls:1.17%
—
—
cases:4.61%
controls:1.29%
cases:24.59%
controls:10.57%
cases:51.06%
controls:29.05%
308
1904
257
3742
161
606
405
5046
32
66
534
5586
—
26
73
538
5570
134
582
411
4922
241
1380
231
3371
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
8.4e-01
1.1e+00
1.7e+00
—
1.4e+00
1.1e+00
7.6e-01
cases:29.20%
controls:15.14%
cases:12.72%
controls:4.58%
cases:3.53%
controls:0.64%
—
—
cases:2.13%
controls:0.53%
cases:13.58%
controls:5.05%
cases:27.54%
controls:15.15%
165
855
400
4791
72
259
494
5393
20
36
546
5616
—
12
30
552
5613
74
278
471
5226
130
720
342
4031
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
6.1e-01
8.9e-01
1.9e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:10.62%
controls:6.04%
cases:7.24%
controls:3.10%
cases:5.12%
controls:0.83%
—
—
cases:2.48%
controls:0.74%
cases:9.36%
controls:2.93%
cases:19.92%
controls:7.96%
60
341
505
5305
41
175
525
5477
29
47
537
5605
—
14
42
550
5601
51
161
494
5343
94
378
378
4373
Internal Medicine
11 [38004456]
11 [38004456]
8.7e-01
1.1e+00
1.3e+00
—
1.2e+00
1.2e+00
1.2e+00
cases:31.33%
controls:16.01%
cases:16.08%
controls:5.93%
cases:3.53%
controls:0.97%
—
—
cases:3.19%
controls:0.99%
cases:16.51%
controls:5.67%
cases:34.96%
controls:14.00%
177
904
388
4742
91
335
475
5317
20
55
546
5597
—
18
56
546
5587
90
312
455
5192
165
665
307
4086
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
1.1e+00
1.9e+00
—
—
—
2.6e+00
1.2e+00
cases:2.30%
controls:0.78%
cases:1.77%
controls:0.27%
—
—
—
—
—
—
cases:2.20%
controls:0.16%
cases:2.54%
controls:0.76%
13
44
552
5602
10
15
556
5637
—
—
—
12
9
533
5495
12
36
460
4715
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
4.1e-01
6.8e-01
1.3e+00
2.1e+00
1.1e+00
6.1e-01
6.1e-01
cases:38.23%
controls:29.17%
cases:35.16%
controls:21.57%
cases:13.78%
controls:4.35%
cases:2.83%
controls:0.35%
cases:11.52%
controls:4.18%
cases:36.15%
controls:23.55%
cases:63.77%
controls:48.85%
216
1647
349
3999
199
1219
367
4433
78
246
488
5406
16
20
550
5632
65
236
499
5407
197
1296
348
4208
301
2321
171
2430
Headache
R51.80 [2000503603]
R51.80 [2000503603]
1.4e+00
2.0e+00
—
—
2.1e+00
1.7e+00
1.7e+00
cases:9.56%
controls:2.57%
cases:4.59%
controls:0.65%
—
—
—
—
cases:0.89%
controls:0.11%
cases:4.40%
controls:0.82%
cases:11.44%
controls:2.42%
54
145
511
5501
26
37
540
5615
—
—
5
6
559
5637
24
45
521
5459
54
115
418
4636
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
7.1e-01
8.5e-01
2.4e+00
—
1.4e+00
1.3e+00
1.4e+00
cases:7.96%
controls:4.07%
cases:4.95%
controls:2.18%
cases:2.30%
controls:0.21%
—
—
cases:1.42%
controls:0.34%
cases:7.16%
controls:2.00%
cases:18.01%
controls:4.90%
45
230
520
5416
28
123
538
5529
13
12
553
5640
—
8
19
556
5624
39
110
506
5394
85
233
387
4518
nortriptyline; oral, parenteral
N06AA10 [21604697]
N06AA10 [21604697]
1.5e+00
1.5e+00
—
—
—
2.3e+00
1.5e+00
cases:4.42%
controls:1.04%
cases:3.53%
controls:0.83%
—
—
—
—
—
—
cases:5.50%
controls:0.60%
cases:6.99%
controls:1.62%
25
59
540
5587
20
47
546
5605
—
—
—
30
33
515
5471
33
77
439
4674
Low back pain
M54.5 [45553207]
M54.5 [45553207]
1.1e+00
1.4e+00
1.8e+00
—
1.4e+00
1.3e+00
1.1e+00
cases:16.64%
controls:6.34%
cases:8.83%
controls:2.25%
cases:1.94%
controls:0.34%
—
—
cases:1.06%
controls:0.27%
cases:8.26%
controls:2.29%
cases:19.70%
controls:7.81%
94
358
471
5288
50
127
516
5525
11
19
555
5633
—
6
15
558
5628
45
126
500
5378
93
371
379
4380
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
WZC10 [2001310887]
1.4e+00
—
—
—
—
2.8e+00
2.5e+00
cases:1.95%
controls:0.50%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.11%
cases:3.60%
controls:0.32%
11
28
554
5618
—
—
—
—
10
6
535
5498
17
15
455
4736
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
4.1e-01
6.0e-01
1.3e+00
2.0e+00
1.2e+00
5.6e-01
6.5e-01
cases:27.96%
controls:20.53%
cases:24.20%
controls:14.93%
cases:10.25%
controls:2.99%
cases:2.12%
controls:0.30%
cases:8.51%
controls:2.85%
cases:25.14%
controls:16.12%
cases:49.15%
controls:33.64%
158
1159
407
4487
137
844
429
4808
58
169
508
5483
12
17
554
5635
48
161
516
5482
137
887
408
4617
232
1598
240
3153
Malaise and fatigue
R53 [45553741]
R53 [45553741]
1.3e+00
1.1e+00
2.0e+00
—
—
1.3e+00
9.9e-01
cases:9.38%
controls:2.87%
cases:4.24%
controls:1.43%
cases:1.24%
controls:0.18%
—
—
—
—
cases:4.22%
controls:1.22%
cases:12.50%
controls:5.03%
53
162
512
5484
24
81
542
5571
7
10
559
5642
—
—
23
67
522
5437
59
239
413
4512
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
8.1e-01
8.8e-01
—
—
2.2e+00
1.4e+00
1.3e+00
cases:9.38%
controls:4.39%
cases:3.53%
controls:1.50%
—
—
—
—
cases:1.06%
controls:0.12%
cases:5.69%
controls:1.47%
cases:16.31%
controls:4.84%
53
248
512
5398
20
85
546
5567
—
—
6
7
558
5636
31
81
514
5423
77
230
395
4521
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
3.1e-01
6.0e-01
1.2e+00
2.2e+00
1.2e+00
7.3e-01
6.8e-01
cases:29.03%
controls:23.01%
cases:28.27%
controls:17.80%
cases:12.01%
controls:4.09%
cases:2.65%
controls:0.30%
cases:11.17%
controls:3.63%
cases:32.29%
controls:18.75%
cases:55.51%
controls:38.64%
164
1299
401
4347
160
1006
406
4646
68
231
498
5421
15
17
551
5635
63
205
501
5438
176
1032
369
4472
262
1836
210
2915
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
1.0e+00
2.1e+00
—
—
—
1.5e+00
1.9e+00
cases:3.72%
controls:1.36%
cases:3.18%
controls:0.41%
—
—
—
—
—
—
cases:2.02%
controls:0.44%
cases:4.66%
controls:0.76%
21
77
544
5569
18
23
548
5629
—
—
—
11
24
534
5480
22
36
450
4715
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
1.0e+00
2.1e+00
—
—
—
1.5e+00
1.9e+00
cases:3.72%
controls:1.36%
cases:3.18%
controls:0.41%
—
—
—
—
—
—
cases:2.02%
controls:0.44%
cases:4.66%
controls:0.76%
21
77
544
5569
18
23
548
5629
—
—
—
11
24
534
5480
22
36
450
4715
Stomatognathic treatment, basic
SHA02 [2001310406]
SHA02 [2001310406]
1.2e+00
1.9e+00
—
—
—
1.5e+00
1.8e+00
cases:4.60%
controls:1.42%
cases:1.94%
controls:0.28%
—
—
—
—
—
—
cases:2.75%
controls:0.60%
cases:9.75%
controls:1.79%
26
80
539
5566
11
16
555
5636
—
—
—
15
33
530
5471
46
85
426
4666
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
1.2e+00
1.3e+00
1.4e+00
—
—
1.6e+00
2.3e+00
cases:2.83%
controls:0.85%
cases:2.12%
controls:0.57%
cases:0.88%
controls:0.23%
—
—
—
—
cases:2.39%
controls:0.51%
cases:5.72%
controls:0.59%
16
48
549
5598
12
32
554
5620
5
13
561
5639
—
—
13
28
532
5476
27
28
445
4723
methylphenidate; oral
N06BA04 [21604757]
N06BA04 [21604757]
1.8e+00
1.5e+00
—
—
1.6e+00
1.8e+00
1.3e+00
cases:3.19%
controls:0.55%
cases:2.65%
controls:0.58%
—
—
—
—
cases:1.06%
controls:0.21%
cases:2.75%
controls:0.47%
cases:4.03%
controls:1.09%
18
31
547
5615
15
33
551
5619
—
—
6
12
558
5631
15
26
530
5478
19
52
453
4699
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
8.7e-01
1.2e+00
1.0e+00
—
1.0e+00
1.2e+00
1.1e+00
cases:29.03%
controls:14.61%
cases:20.85%
controls:7.41%
cases:4.24%
controls:1.54%
—
—
cases:3.72%
controls:1.35%
cases:21.10%
controls:7.58%
cases:38.14%
controls:17.11%
164
825
401
4821
118
419
448
5233
24
87
542
5565
—
21
76
543
5567
115
417
430
5087
180
813
292
3938
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
1.2e+00
1.3e+00
1.4e+00
—
1.1e+00
1.4e+00
1.1e+00
cases:8.32%
controls:2.67%
cases:6.36%
controls:1.88%
cases:2.47%
controls:0.62%
—
—
cases:2.13%
controls:0.71%
cases:7.52%
controls:1.89%
cases:9.11%
controls:3.24%
47
151
518
5495
36
106
530
5546
14
35
552
5617
—
12
40
552
5603
41
104
504
5400
43
154
429
4597
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
1.3e+00
1.5e+00
—
1.0e+50
—
1.7e+00
1.8e+00
cases:6.37%
controls:1.81%
cases:3.18%
controls:0.73%
—
—
cases:1.59%
controls:0.00%
—
—
cases:4.22%
controls:0.76%
cases:9.11%
controls:1.62%
36
102
529
5544
18
41
548
5611
—
9
0
557
5652
—
23
42
522
5462
43
77
429
4674
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.5e+00
1.9e+00
—
—
—
1.5e+00
1.3e+00
cases:9.20%
controls:2.11%
cases:4.06%
controls:0.60%
—
—
—
—
—
—
cases:3.85%
controls:0.85%
cases:9.11%
controls:2.59%
52
119
513
5527
23
34
543
5618
—
—
—
21
47
524
5457
43
123
429
4628
Rheumatology
66 [38004491]
66 [38004491]
1.0e+00
1.2e+00
8.0e-01
1.0e+50
1.7e+00
1.3e+00
1.2e+00
cases:9.38%
controls:3.65%
cases:6.89%
controls:2.21%
cases:1.06%
controls:0.48%
cases:5.83%
controls:0.00%
cases:2.84%
controls:0.55%
cases:7.16%
controls:2.13%
cases:10.59%
controls:3.45%
53
206
512
5440
39
125
527
5527
6
27
560
5625
33
0
533
5652
16
31
548
5612
39
117
506
5387
50
164
422
4587
Myalgia
M79.1 [45587062]
M79.1 [45587062]
1.5e+00
1.5e+00
—
—
—
1.9e+00
1.4e+00
cases:7.79%
controls:1.84%
cases:3.36%
controls:0.76%
—
—
—
—
—
—
cases:4.77%
controls:0.73%
cases:9.96%
controls:2.76%
44
104
521
5542
19
43
547
5609
—
—
—
26
40
519
5464
47
131
425
4620
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
SPAT1215 [2001700316]
1.5e+00
2.0e+00
—
—
—
2.3e+00
2.5e+00
cases:2.12%
controls:0.48%
cases:0.88%
controls:0.12%
—
—
—
—
—
—
cases:1.10%
controls:0.11%
cases:3.81%
controls:0.34%
12
27
553
5619
5
7
561
5645
—
—
—
6
6
539
5498
18
16
454
4735
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.5e-01
-4.4e-01
1.0e-01
—
—
3.4e+00
3.5e+00
cases:16.46%
controls:25.40%
cases:5.83%
controls:8.76%
cases:0.88%
controls:0.80%
—
—
—
—
cases:8.62%
controls:0.33%
cases:23.73%
controls:0.97%
93
1434
472
4212
33
495
533
5157
5
45
561
5607
—
—
47
18
498
5486
112
46
360
4705
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
1.3e+00
1.5e+00
1.5e+00
1.0e+50
—
1.8e+00
1.6e+00
cases:6.19%
controls:1.74%
cases:2.83%
controls:0.62%
cases:0.88%
controls:0.19%
cases:1.41%
controls:0.00%
—
—
cases:3.49%
controls:0.62%
cases:7.63%
controls:1.60%
35
98
530
5548
16
35
550
5617
5
11
561
5641
8
0
558
5652
—
19
34
526
5470
36
76
436
4675
Brachial plexus disorders
G54.0 [45586302]
G54.0 [45586302]
2.1e+00
2.5e+00
—
—
—
2.1e+00
1.6e+00
cases:2.48%
controls:0.30%
cases:1.94%
controls:0.16%
—
—
—
—
—
—
cases:0.92%
controls:0.11%
cases:2.33%
controls:0.48%
14
17
551
5629
11
9
555
5643
—
—
—
5
6
540
5498
11
23
461
4728
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
Z03.5 [45590692]
1.5e+00
1.5e+00
—
—
—
2.8e+00
1.9e+00
cases:2.83%
controls:0.64%
cases:1.06%
controls:0.23%
—
—
—
—
—
—
cases:4.77%
controls:0.29%
cases:6.14%
controls:0.99%
16
36
549
5610
6
13
560
5639
—
—
—
26
16
519
5488
29
47
443
4704
Migraine without aura [common migraine]
G43.0 [45600784]
G43.0 [45600784]
1.2e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.5e+00
cases:5.13%
controls:1.68%
cases:3.36%
controls:0.69%
—
—
cases:1.06%
controls:0.00%
—
—
cases:3.67%
controls:0.53%
cases:8.69%
controls:2.08%
29
95
536
5551
19
39
547
5613
—
6
0
560
5652
—
20
29
525
5475
41
99
431
4652
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
1.4e+00
1.7e+00
—
—
—
1.8e+00
1.3e+00
cases:4.07%
controls:1.06%
cases:2.30%
controls:0.41%
—
—
—
—
—
—
cases:2.02%
controls:0.35%
cases:3.81%
controls:1.05%
23
60
542
5586
13
23
553
5629
—
—
—
11
19
534
5485
18
50
454
4701
Emergency Medicine
93 [38004510]
93 [38004510]
6.1e-01
1.0e+00
1.6e+00
—
1.2e+00
1.0e+00
6.9e-01
cases:20.71%
controls:12.47%
cases:16.61%
controls:6.76%
cases:4.24%
controls:0.85%
—
—
cases:3.55%
controls:1.05%
cases:16.88%
controls:6.94%
cases:35.17%
controls:21.45%
117
704
448
4942
94
382
472
5270
24
48
542
5604
—
20
59
544
5584
92
382
453
5122
166
1019
306
3732
Musculoskeletal sympt/complt other
L29 [2002000648]
L29 [2002000648]
1.1e+00
2.2e+00
—
—
—
1.7e+00
1.2e+00
cases:3.01%
controls:1.03%
cases:2.30%
controls:0.27%
—
—
—
—
—
—
cases:2.02%
controls:0.36%
cases:4.45%
controls:1.43%
17
58
548
5588
13
15
553
5637
—
—
—
11
20
534
5484
21
68
451
4683
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
1.8e+00
2.2e+00
—
—
—
1.7e+00
2.1e+00
cases:3.36%
controls:0.55%
cases:1.24%
controls:0.14%
—
—
—
—
—
—
cases:0.92%
controls:0.16%
cases:3.60%
controls:0.44%
19
31
546
5615
7
8
559
5644
—
—
—
5
9
540
5495
17
21
455
4730
Special examination, unspecified
Z01.9 [45576123]
Z01.9 [45576123]
1.6e+00
—
—
—
—
2.7e+00
1.8e+00
cases:1.77%
controls:0.37%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.11%
cases:2.54%
controls:0.42%
10
21
555
5625
—
—
—
—
9
6
536
5498
12
20
460
4731
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
9.0e-01
1.8e+00
—
—
—
2.2e+00
1.2e+00
cases:5.49%
controls:2.30%
cases:2.83%
controls:0.50%
—
—
—
—
—
—
cases:3.12%
controls:0.36%
cases:5.51%
controls:1.66%
31
130
534
5516
16
28
550
5624
—
—
—
17
20
528
5484
26
79
446
4672
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
7.8e-01
8.4e-01
—
—
2.0e+00
1.2e+00
1.2e+00
cases:10.09%
controls:4.89%
cases:4.95%
controls:2.19%
—
—
—
—
cases:1.24%
controls:0.18%
cases:5.87%
controls:1.85%
cases:16.53%
controls:5.41%
57
276
508
5370
28
124
538
5528
—
—
7
10
557
5633
32
102
513
5402
78
257
394
4494
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
1.3e+00
1.7e+00
—
—
—
1.6e+00
1.5e+00
cases:10.44%
controls:3.15%
cases:4.59%
controls:0.87%
—
—
—
—
—
—
cases:3.67%
controls:0.80%
cases:11.44%
controls:2.86%
59
178
506
5468
26
49
540
5603
—
—
—
20
44
525
5460
54
136
418
4615
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
3.2e-01
5.0e-01
7.5e-01
3.4e+00
8.8e-01
4.9e-01
3.9e-01
cases:75.93%
controls:69.68%
cases:73.50%
controls:62.74%
cases:42.76%
controls:26.03%
cases:32.33%
controls:1.61%
cases:44.33%
controls:24.86%
cases:75.41%
controls:65.32%
cases:88.14%
controls:83.48%
429
3934
136
1712
416
3546
150
2106
242
1471
324
4181
183
91
383
5561
250
1403
314
4240
411
3595
134
1909
416
3966
56
785
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
5.7e-01
9.9e-01
1.6e+00
—
1.7e+00
1.0e+00
7.1e-01
cases:7.61%
controls:4.46%
cases:4.06%
controls:1.56%
cases:1.59%
controls:0.34%
—
—
cases:1.95%
controls:0.37%
cases:4.22%
controls:1.58%
cases:6.99%
controls:3.56%
43
252
522
5394
23
88
543
5564
9
19
557
5633
—
11
21
553
5622
23
87
522
5417
33
169
439
4582
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
1.1e+00
9.2e-01
1.9e+00
—
—
1.1e+00
9.7e-01
cases:19.82%
controls:7.86%
cases:6.01%
controls:2.49%
cases:1.41%
controls:0.21%
—
—
—
—
cases:8.07%
controls:2.96%
cases:19.28%
controls:8.27%
112
444
453
5202
34
141
532
5511
8
12
558
5640
—
—
44
163
501
5341
91
393
381
4358
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
1.1e+00
9.2e-01
1.9e+00
—
—
1.1e+00
9.7e-01
cases:19.82%
controls:7.86%
cases:6.01%
controls:2.49%
cases:1.41%
controls:0.21%
—
—
—
—
cases:8.07%
controls:2.96%
cases:19.28%
controls:8.27%
112
444
453
5202
34
141
532
5511
8
12
558
5640
—
—
44
163
501
5341
91
393
381
4358
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
7.2e-01
1.1e+00
1.2e+00
—
1.8e+00
1.3e+00
1.0e+00
cases:14.87%
controls:7.81%
cases:9.01%
controls:3.22%
cases:1.41%
controls:0.42%
—
—
cases:2.13%
controls:0.37%
cases:9.54%
controls:2.80%
cases:18.64%
controls:7.60%
84
441
481
5205
51
182
515
5470
8
24
558
5628
—
12
21
552
5622
52
154
493
5350
88
361
384
4390
Dysphagia
R13 [45573013]
R13 [45573013]
8.5e-01
2.3e+00
—
—
—
1.9e+00
1.7e+00
cases:1.24%
controls:0.53%
cases:1.24%
controls:0.12%
—
—
—
—
—
—
cases:1.28%
controls:0.20%
cases:2.97%
controls:0.55%
7
30
558
5616
7
7
559
5645
—
—
—
7
11
538
5493
14
26
458
4725
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
1.5e+00
—
—
—
—
2.3e+00
2.1e+00
cases:1.95%
controls:0.46%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.13%
cases:2.97%
controls:0.38%
11
26
554
5620
—
—
—
—
7
7
538
5497
14
18
458
4733
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
8.7e-01
2.0e+00
—
—
—
2.2e+00
1.7e+00
cases:1.59%
controls:0.67%
cases:1.24%
controls:0.18%
—
—
—
—
—
—
cases:1.10%
controls:0.13%
cases:3.18%
controls:0.59%
9
38
556
5608
7
10
559
5642
—
—
—
6
7
539
5497
15
28
457
4723
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
SPAT1223 [2001700324]
1.1e+00
1.5e+00
1.3e+00
—
—
1.7e+00
1.5e+00
cases:11.15%
controls:3.83%
cases:6.18%
controls:1.40%
cases:1.06%
controls:0.28%
—
—
—
—
cases:7.52%
controls:1.51%
cases:15.25%
controls:4.00%
63
216
502
5430
35
79
531
5573
6
16
560
5636
—
—
41
83
504
5421
72
190
400
4561
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
7.9e-01
7.2e-01
1.3e+00
—
1.5e+00
7.7e-01
6.8e-01
cases:27.08%
controls:14.42%
cases:10.07%
controls:5.17%
cases:1.94%
controls:0.53%
—
—
cases:2.84%
controls:0.62%
cases:10.09%
controls:4.94%
cases:23.73%
controls:13.64%
153
814
412
4832
57
292
509
5360
11
30
555
5622
—
16
35
548
5608
55
272
490
5232
112
648
360
4103
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
1.1e+00
1.2e+00
1.3e+00
—
4.2e-01
1.2e+00
9.9e-01
cases:14.51%
controls:5.54%
cases:8.83%
controls:2.83%
cases:2.12%
controls:0.60%
—
—
cases:0.89%
controls:0.58%
cases:9.72%
controls:3.05%
cases:14.19%
controls:5.77%
82
313
483
5333
50
160
516
5492
12
34
554
5618
—
5
33
559
5610
53
168
492
5336
67
274
405
4477
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
1.3e+00
1.3e+00
2.0e+00
—
2.1e+00
1.5e+00
1.6e+00
cases:4.42%
controls:1.26%
cases:2.12%
controls:0.57%
cases:0.88%
controls:0.12%
—
—
cases:0.89%
controls:0.11%
cases:2.94%
controls:0.65%
cases:9.11%
controls:2.06%
25
71
540
5575
12
32
554
5620
5
7
561
5645
—
5
6
559
5637
16
36
529
5468
43
98
429
4653
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
1.1e+00
1.5e+00
—
—
—
1.9e+00
1.3e+00
cases:3.72%
controls:1.33%
cases:2.30%
controls:0.53%
—
—
—
—
—
—
cases:2.57%
controls:0.40%
cases:4.66%
controls:1.33%
21
75
544
5571
13
30
553
5622
—
—
—
14
22
531
5482
22
63
450
4688
celecoxib
L01XX33 [21603805]
L01XX33 [21603805]
1.3e+00
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:4.96%
controls:1.42%
cases:1.77%
controls:0.44%
—
—
—
—
—
—
cases:1.83%
controls:0.38%
cases:4.24%
controls:1.05%
28
80
537
5566
10
25
556
5627
—
—
—
10
21
535
5483
20
50
452
4701
celecoxib; oral
M01AH01 [21603992]
M01AH01 [21603992]
1.3e+00
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:4.96%
controls:1.42%
cases:1.77%
controls:0.44%
—
—
—
—
—
—
cases:1.83%
controls:0.38%
cases:4.24%
controls:1.05%
28
80
537
5566
10
25
556
5627
—
—
—
10
21
535
5483
20
50
452
4701
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
7.3e-01
1.1e+00
8.4e-01
—
2.0e+00
9.6e-01
9.1e-01
cases:19.65%
controls:10.57%
cases:9.54%
controls:3.43%
cases:1.06%
controls:0.46%
—
—
cases:2.84%
controls:0.39%
cases:7.71%
controls:3.11%
cases:16.95%
controls:7.62%
111
597
454
5049
54
194
512
5458
6
26
560
5626
—
16
22
548
5621
42
171
503
5333
80
362
392
4389
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
5.3e-01
6.6e-01
1.4e+00
—
1.4e+00
7.8e-01
8.9e-01
cases:20.35%
controls:13.09%
cases:12.19%
controls:6.67%
cases:3.36%
controls:0.81%
—
—
cases:2.84%
controls:0.73%
cases:13.94%
controls:6.92%
cases:37.29%
controls:19.68%
115
739
450
4907
69
377
497
5275
19
46
547
5606
—
16
41
548
5602
76
381
469
5123
176
935
296
3816
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
7.4e-01
8.1e-01
7.8e-01
—
1.7e+00
1.2e+00
1.2e+00
cases:11.15%
controls:5.63%
cases:5.65%
controls:2.60%
cases:0.88%
controls:0.41%
—
—
cases:1.42%
controls:0.27%
cases:7.89%
controls:2.42%
cases:19.70%
controls:6.84%
63
318
502
5328
32
147
534
5505
5
23
561
5629
—
8
15
556
5628
43
133
502
5371
93
325
379
4426
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
1.6e+00
2.0e+00
—
—
—
1.3e+00
2.1e+00
cases:4.07%
controls:0.87%
cases:1.77%
controls:0.25%
—
—
—
—
—
—
cases:1.10%
controls:0.29%
cases:5.51%
controls:0.69%
23
49
542
5597
10
14
556
5638
—
—
—
6
16
539
5488
26
33
446
4718
Migraine, unspecified
G43.9 [45595943]
G43.9 [45595943]
1.2e+00
1.5e+00
—
—
—
1.6e+00
1.4e+00
cases:5.13%
controls:1.66%
cases:2.83%
controls:0.67%
—
—
—
—
—
—
cases:2.94%
controls:0.62%
cases:7.84%
controls:2.02%
29
94
536
5552
16
38
550
5614
—
—
—
16
34
529
5470
37
96
435
4655
Dislocation of shoulder joint
S43.0 [45573622]
S43.0 [45573622]
1.5e+00
2.9e+00
—
—
—
1.8e+00
2.7e+00
cases:1.42%
controls:0.32%
cases:1.59%
controls:0.09%
—
—
—
—
—
—
cases:0.92%
controls:0.15%
cases:2.75%
controls:0.19%
8
18
557
5628
9
5
557
5647
—
—
—
5
8
540
5496
13
9
459
4742
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.3e-01
5.4e-01
1.0e+00
2.1e+00
9.7e-01
5.1e-01
4.7e-01
cases:40.35%
controls:34.93%
cases:40.64%
controls:28.57%
cases:15.72%
controls:6.14%
cases:3.36%
controls:0.44%
cases:13.65%
controls:5.64%
cases:42.94%
controls:31.03%
cases:69.70%
controls:59.02%
228
1972
337
3674
230
1615
336
4037
89
347
477
5305
19
25
547
5627
77
318
487
5325
234
1708
311
3796
329
2804
143
1947
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
1.1e+00
1.3e+00
2.0e+00
—
—
1.6e+00
1.6e+00
cases:6.73%
controls:2.39%
cases:3.00%
controls:0.81%
cases:0.88%
controls:0.12%
—
—
—
—
cases:4.22%
controls:0.87%
cases:9.96%
controls:2.25%
38
135
527
5511
17
46
549
5606
5
7
561
5645
—
—
23
48
522
5456
47
107
425
4644
Inpatient Hospital
21 [8717]
21 [8717]
6.2e-01
7.0e-01
1.1e+00
—
1.4e+00
1.0e+00
6.9e-01
cases:45.13%
controls:30.66%
cases:16.78%
controls:9.09%
cases:3.36%
controls:1.11%
—
—
cases:4.08%
controls:1.03%
cases:20.37%
controls:8.34%
cases:36.86%
controls:22.65%
255
1731
310
3915
95
514
471
5138
19
63
547
5589
—
23
58
541
5585
111
459
434
5045
174
1076
298
3675
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
5.4e-01
1.3e+00
—
1.0e+50
—
2.5e+00
1.8e+00
cases:2.83%
controls:1.66%
cases:2.30%
controls:0.62%
—
—
cases:1.94%
controls:0.00%
—
—
cases:6.24%
controls:0.55%
cases:9.75%
controls:1.83%
16
94
549
5552
13
35
553
5617
—
11
0
555
5652
—
34
30
511
5474
46
87
426
4664
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.4e-01
5.3e-01
1.1e+00
2.0e+00
9.7e-01
5.2e-01
4.8e-01
cases:40.35%
controls:34.84%
cases:40.28%
controls:28.47%
cases:15.72%
controls:6.09%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.65%
cases:42.75%
controls:30.81%
cases:69.70%
controls:58.72%
228
1967
337
3679
228
1609
338
4043
89
344
477
5308
18
25
548
5627
77
319
487
5324
233
1696
312
3808
329
2790
143
1961
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.8e-01
5.6e-01
8.8e-01
2.1e+00
1.0e+00
5.4e-01
4.5e-01
cases:36.11%
controls:29.83%
cases:30.04%
controls:19.67%
cases:8.30%
controls:3.61%
cases:2.12%
controls:0.27%
cases:8.16%
controls:3.12%
cases:30.28%
controls:20.15%
cases:58.47%
controls:47.19%
204
1684
361
3962
170
1112
396
4540
47
204
519
5448
12
15
554
5637
46
176
518
5467
165
1109
380
4395
276
2242
196
2509
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.3e-01
5.3e-01
1.1e+00
2.0e+00
9.8e-01
5.1e-01
4.8e-01
cases:40.35%
controls:34.95%
cases:40.46%
controls:28.52%
cases:15.72%
controls:6.10%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.62%
cases:42.75%
controls:31.01%
cases:69.92%
controls:59.00%
228
1973
337
3673
229
1612
337
4040
89
345
477
5307
18
25
548
5627
77
317
487
5326
233
1707
312
3797
330
2803
142
1948
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
1.1e+00
1.8e+00
—
—
—
1.6e+00
1.0e+00
cases:6.73%
controls:2.36%
cases:2.30%
controls:0.39%
—
—
—
—
—
—
cases:3.67%
controls:0.74%
cases:5.93%
controls:2.21%
38
133
527
5513
13
22
553
5630
—
—
—
20
41
525
5463
28
105
444
4646
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.3e-01
5.3e-01
1.1e+00
2.0e+00
9.7e-01
5.1e-01
4.7e-01
cases:40.35%
controls:34.89%
cases:40.46%
controls:28.52%
cases:15.72%
controls:6.10%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.64%
cases:42.75%
controls:31.01%
cases:69.70%
controls:58.98%
228
1970
337
3676
229
1612
337
4040
89
345
477
5307
18
25
548
5627
77
318
487
5325
233
1707
312
3797
329
2802
143
1949
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.3e-01
5.3e-01
1.1e+00
2.0e+00
9.7e-01
5.1e-01
4.7e-01
cases:40.35%
controls:34.95%
cases:40.46%
controls:28.56%
cases:15.72%
controls:6.12%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.64%
cases:42.75%
controls:31.05%
cases:69.70%
controls:59.00%
228
1973
337
3673
229
1614
337
4038
89
346
477
5306
18
25
548
5627
77
318
487
5325
233
1709
312
3795
329
2803
143
1948
Cluster headache syndrome
G44.0 [45533141]
G44.0 [45533141]
2.0e+00
—
—
—
—
—
3.5e+00
cases:1.06%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:3.39%
controls:0.11%
6
8
559
5638
—
—
—
—
—
16
5
456
4746
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.3e-01
5.3e-01
1.0e+00
2.0e+00
9.7e-01
5.0e-01
4.6e-01
cases:40.35%
controls:34.87%
cases:40.46%
controls:28.63%
cases:15.72%
controls:6.14%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.64%
cases:42.75%
controls:31.09%
cases:69.70%
controls:59.15%
228
1969
337
3677
229
1618
337
4034
89
347
477
5305
18
25
548
5627
77
318
487
5325
233
1711
312
3793
329
2810
143
1941
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.3e-01
5.3e-01
1.0e+00
2.0e+00
9.6e-01
5.1e-01
4.6e-01
cases:40.35%
controls:35.00%
cases:40.46%
controls:28.64%
cases:15.72%
controls:6.16%
cases:3.18%
controls:0.44%
cases:13.65%
controls:5.69%
cases:42.75%
controls:31.03%
cases:69.70%
controls:59.10%
228
1976
337
3670
229
1619
337
4033
89
348
477
5304
18
25
548
5627
77
321
487
5322
233
1708
312
3796
329
2808
143
1943
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
R5110 [2001310246]
1.4e+00
1.6e+00
—
—
—
2.0e+00
2.0e+00
cases:4.07%
controls:0.99%
cases:1.41%
controls:0.30%
—
—
—
—
—
—
cases:3.30%
controls:0.45%
cases:9.96%
controls:1.45%
23
56
542
5590
8
17
558
5635
—
—
—
18
25
527
5479
47
69
425
4682
Oral Surgery
19 [38004464]
19 [38004464]
1.5e+00
2.1e+00
—
—
—
1.4e+00
1.8e+00
cases:3.89%
controls:0.87%
cases:1.94%
controls:0.25%
—
—
—
—
—
—
cases:1.65%
controls:0.40%
cases:6.14%
controls:1.03%
22
49
543
5597
11
14
555
5638
—
—
—
9
22
536
5482
29
49
443
4702
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
1.0e+00
2.0e+00
—
—
2.3e+00
1.5e+00
9.9e-01
cases:8.50%
controls:3.28%
cases:5.83%
controls:0.85%
—
—
—
—
cases:0.89%
controls:0.09%
cases:3.49%
controls:0.84%
cases:9.32%
controls:3.68%
48
185
517
5461
33
48
533
5604
—
—
5
5
559
5638
19
46
526
5458
44
175
428
4576
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
9.4e-01
1.3e+00
—
1.0e+50
—
1.7e+00
1.4e+00
cases:6.90%
controls:2.82%
cases:4.06%
controls:1.10%
—
—
cases:1.77%
controls:0.00%
—
—
cases:5.69%
controls:1.07%
cases:11.65%
controls:3.05%
39
159
526
5487
23
62
543
5590
—
10
0
556
5652
—
31
59
514
5445
55
145
417
4606
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
1.4e+00
1.5e+00
—
—
—
2.2e+00
1.8e+00
cases:3.72%
controls:0.92%
cases:1.24%
controls:0.28%
—
—
—
—
—
—
cases:3.49%
controls:0.40%
cases:7.84%
controls:1.39%
21
52
544
5594
7
16
559
5636
—
—
—
19
22
526
5482
37
66
435
4685
agomelatine; oral
N06AX22 [21604750]
N06AX22 [21604750]
1.2e+00
2.0e+00
—
—
—
1.8e+00
1.6e+00
cases:1.42%
controls:0.43%
cases:1.24%
controls:0.18%
—
—
—
—
—
—
cases:1.65%
controls:0.27%
cases:2.75%
controls:0.55%
8
24
557
5622
7
10
559
5642
—
—
—
9
15
536
5489
13
26
459
4725
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
8.9e-01
1.4e+00
—
—
—
1.8e+00
1.3e+00
cases:5.84%
controls:2.48%
cases:3.18%
controls:0.78%
—
—
—
—
—
—
cases:4.59%
controls:0.82%
cases:8.90%
controls:2.59%
33
140
532
5506
18
44
548
5608
—
—
—
25
45
520
5459
42
123
430
4628
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
N07BC01 [21604826]
2.3e+00
—
—
—
—
—
3.0e+00
cases:2.48%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:3.81%
controls:0.19%
14
14
551
5632
—
—
—
—
—
18
9
454
4742
Neurosurgery
14 [38004459]
14 [38004459]
9.7e-01
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:4.42%
controls:1.72%
cases:2.47%
controls:0.64%
—
—
—
—
—
—
cases:2.75%
controls:0.58%
cases:6.78%
controls:1.70%
25
97
540
5549
14
36
552
5616
—
—
—
15
32
530
5472
32
81
440
4670
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
5.8e-01
6.9e-01
1.2e+00
1.9e+00
1.0e+00
8.8e-01
9.9e-01
cases:25.49%
controls:16.10%
cases:17.49%
controls:9.57%
cases:5.83%
controls:1.80%
cases:1.06%
controls:0.16%
cases:4.43%
controls:1.68%
cases:20.18%
controls:9.52%
cases:45.13%
controls:23.36%
144
909
421
4737
99
541
467
5111
33
102
533
5550
6
9
560
5643
25
95
539
5548
110
524
435
4980
213
1110
259
3641
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
1.1e+00
1.6e+00
—
—
—
1.5e+00
1.1e+00
cases:7.79%
controls:2.69%
cases:5.12%
controls:1.06%
—
—
—
—
—
—
cases:4.22%
controls:1.00%
cases:9.96%
controls:3.45%
44
152
521
5494
29
60
537
5592
—
—
—
23
55
522
5449
47
164
425
4587
immunoglobulins, normal human, for extravascular adm.
J06BA01 [21601256]
J06BA01 [21601256]
—
2.6e+00
—
—
—
2.7e+00
—
—
—
cases:1.24%
controls:0.09%
—
—
—
—
—
—
cases:1.28%
controls:0.09%
—
—
—
7
5
559
5647
—
—
—
7
5
538
5499
—
immunoglobulins, normal human, for intravascular adm.
J06BA02 [21601257]
J06BA02 [21601257]
—
2.6e+00
—
—
—
2.7e+00
—
—
—
cases:1.24%
controls:0.09%
—
—
—
—
—
—
cases:1.28%
controls:0.09%
—
—
—
7
5
559
5647
—
—
—
7
5
538
5499
—
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
6.2e-01
1.8e+00
—
—
—
2.0e+00
1.6e+00
cases:1.77%
controls:0.96%
cases:1.94%
controls:0.34%
—
—
—
—
—
—
cases:1.28%
controls:0.18%
cases:3.39%
controls:0.74%
10
54
555
5592
11
19
555
5633
—
—
—
7
10
538
5494
16
35
456
4716
Lumbago with sciatica
M54.4 [45553205]
M54.4 [45553205]
1.1e+00
1.1e+00
2.3e+00
—
—
1.7e+00
1.4e+00
cases:6.02%
controls:2.09%
cases:3.00%
controls:1.01%
cases:0.88%
controls:0.09%
—
—
—
—
cases:4.59%
controls:0.85%
cases:10.38%
controls:2.90%
34
118
531
5528
17
57
549
5595
5
5
561
5647
—
—
25
47
520
5457
49
138
423
4613
Dysthymia
F34.1 [45586238]
F34.1 [45586238]
1.4e+00
2.0e+00
—
—
—
1.9e+00
1.1e+00
cases:1.95%
controls:0.50%
cases:2.12%
controls:0.28%
—
—
—
—
—
—
cases:1.83%
controls:0.29%
cases:2.54%
controls:0.86%
11
28
554
5618
12
16
554
5636
—
—
—
10
16
535
5488
12
41
460
4710
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
7.0e-01
1.6e+00
—
-1.0e+50
1.7e+00
2.1e+00
1.6e+00
cases:2.12%
controls:1.06%
cases:2.65%
controls:0.55%
—
—
cases:0.00%
controls:0.09%
cases:0.89%
controls:0.16%
cases:4.59%
controls:0.60%
cases:8.90%
controls:1.94%
12
60
553
5586
15
31
551
5621
—
0
5
566
5647
5
9
559
5634
25
33
520
5471
42
92
430
4659
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
9.5e-01
1.0e+00
—
1.0e+50
—
1.8e+00
1.5e+00
cases:12.57%
controls:5.24%
cases:4.06%
controls:1.49%
—
—
cases:1.59%
controls:0.00%
—
—
cases:4.40%
controls:0.76%
cases:12.08%
controls:3.01%
71
296
494
5350
23
84
543
5568
—
9
0
557
5652
—
24
42
521
5462
57
143
415
4608
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
9.6e-01
1.2e+00
—
1.0e+50
—
1.6e+00
1.4e+00
cases:7.61%
controls:3.06%
cases:3.00%
controls:0.92%
—
—
cases:0.88%
controls:0.00%
—
—
cases:3.49%
controls:0.73%
cases:7.84%
controls:1.96%
43
173
522
5473
17
52
549
5600
—
5
0
561
5652
—
19
40
526
5464
37
93
435
4658
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.3e+00
1.1e+00
—
—
—
1.5e+00
1.3e+00
cases:6.02%
controls:1.70%
cases:2.47%
controls:0.81%
—
—
—
—
—
—
cases:3.12%
controls:0.73%
cases:7.42%
controls:2.19%
34
96
531
5550
14
46
552
5606
—
—
—
17
40
528
5464
35
104
437
4647
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
1.3e+00
9.7e-01
—
—
—
2.2e+00
1.7e+00
cases:3.54%
controls:0.97%
cases:0.88%
controls:0.34%
—
—
—
—
—
—
cases:2.39%
controls:0.27%
cases:4.03%
controls:0.78%
20
55
545
5591
5
19
561
5633
—
—
—
13
15
532
5489
19
37
453
4714
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
1.2e+00
—
—
—
—
1.7e+00
2.3e+00
cases:3.54%
controls:1.13%
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.27%
cases:7.20%
controls:0.76%
20
64
545
5582
—
—
—
—
8
15
537
5489
34
36
438
4715
Migraine
G43 [45566873]
G43 [45566873]
1.5e+00
1.4e+00
-1.0e+50
—
-1.0e+50
1.4e+00
8.4e-01
cases:4.42%
controls:1.03%
cases:2.47%
controls:0.60%
cases:0.00%
controls:0.12%
—
—
cases:0.00%
controls:0.09%
cases:2.75%
controls:0.69%
cases:5.08%
controls:2.25%
25
58
540
5588
14
34
552
5618
0
7
566
5645
—
0
5
564
5638
15
38
530
5466
24
107
448
4644
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
7.6e-01
1.7e+00
—
—
—
2.0e+00
1.5e+00
cases:1.95%
controls:0.92%
cases:1.94%
controls:0.35%
—
—
—
—
—
—
cases:1.28%
controls:0.18%
cases:3.18%
controls:0.74%
11
52
554
5594
11
20
555
5632
—
—
—
7
10
538
5494
15
35
457
4716
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
7.8e-01
7.1e-01
1.2e+00
—
1.6e+00
9.9e-01
1.1e+00
cases:14.87%
controls:7.44%
cases:7.95%
controls:4.07%
cases:1.94%
controls:0.62%
—
—
cases:2.48%
controls:0.51%
cases:9.72%
controls:3.83%
cases:27.12%
controls:11.09%
84
420
481
5226
45
230
521
5422
11
35
555
5617
—
14
29
550
5614
53
211
492
5293
128
527
344
4224
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
1.3e+00
1.3e+00
—
—
—
1.3e+00
1.2e+00
cases:5.84%
controls:1.61%
cases:2.12%
controls:0.58%
—
—
—
—
—
—
cases:2.02%
controls:0.56%
cases:6.14%
controls:1.89%
33
91
532
5555
12
33
554
5619
—
—
—
11
31
534
5473
29
90
443
4661
Spinal stenosis
M48.0 [45557888]
M48.0 [45557888]
1.4e+00
1.0e+00
—
—
—
2.0e+00
1.7e+00
cases:2.65%
controls:0.66%
cases:1.24%
controls:0.46%
—
—
—
—
—
—
cases:2.75%
controls:0.38%
cases:4.24%
controls:0.78%
15
37
550
5609
7
26
559
5626
—
—
—
15
21
530
5483
20
37
452
4714
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
2.0e-01
2.2e-01
1.6e+00
—
1.8e+00
1.1e+00
7.0e-01
cases:10.62%
controls:8.87%
cases:4.77%
controls:3.86%
cases:2.12%
controls:0.44%
—
—
cases:2.13%
controls:0.37%
cases:9.54%
controls:3.38%
cases:20.55%
controls:11.43%
60
501
505
5145
27
218
539
5434
12
25
554
5627
—
12
21
552
5622
52
186
493
5318
97
543
375
4208
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
9.5e-01
9.6e-01
1.0e+00
—
1.3e+00
9.4e-01
9.8e-01
cases:12.57%
controls:5.26%
cases:6.54%
controls:2.60%
cases:1.59%
controls:0.57%
—
—
cases:2.48%
controls:0.69%
cases:6.24%
controls:2.53%
cases:13.98%
controls:5.75%
71
297
494
5349
37
147
529
5505
9
32
557
5620
—
14
39
550
5604
34
139
511
5365
66
273
406
4478
Dentistry
C5 [903277]
C5 [903277]
9.3e-01
1.3e+00
—
—
2.0e+00
1.4e+00
1.4e+00
cases:5.66%
controls:2.32%
cases:3.18%
controls:0.87%
—
—
—
—
cases:0.89%
controls:0.12%
cases:4.22%
controls:1.04%
cases:9.75%
controls:2.50%
32
131
533
5515
18
49
548
5603
—
—
5
7
559
5636
23
57
522
5447
46
119
426
4632
Low back symptom/complaint
L03 [2002000628]
L03 [2002000628]
5.6e-01
9.0e-01
2.0e+00
—
—
1.1e+00
1.1e+00
cases:7.26%
controls:4.27%
cases:4.06%
controls:1.70%
cases:1.41%
controls:0.19%
—
—
—
—
cases:4.77%
controls:1.60%
cases:14.41%
controls:5.39%
41
241
524
5405
23
96
543
5556
8
11
558
5641
—
—
26
88
519
5416
68
256
404
4495
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
6.5e-01
1.9e+00
—
1.0e+50
—
1.8e+00
1.4e+00
cases:2.12%
controls:1.12%
cases:1.59%
controls:0.23%
—
—
cases:0.88%
controls:0.00%
—
—
cases:2.39%
controls:0.42%
cases:3.81%
controls:0.99%
12
63
553
5583
9
13
557
5639
—
5
0
561
5652
—
13
23
532
5481
18
47
454
4704
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
1.7e+00
1.3e+00
—
—
1.7e+00
1.8e+00
1.6e+00
cases:3.89%
controls:0.76%
cases:1.59%
controls:0.42%
—
—
—
—
cases:1.06%
controls:0.19%
cases:2.20%
controls:0.38%
cases:4.03%
controls:0.80%
22
43
543
5603
9
24
557
5628
—
—
6
11
558
5632
12
21
533
5483
19
38
453
4713
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
8.1e-01
7.0e-01
1.8e+00
—
7.8e-01
8.0e-01
9.9e-01
cases:14.51%
controls:7.00%
cases:8.30%
controls:4.30%
cases:2.12%
controls:0.37%
—
—
cases:0.89%
controls:0.41%
cases:9.54%
controls:4.54%
cases:29.24%
controls:13.28%
82
395
483
5251
47
243
519
5409
12
21
554
5631
—
5
23
559
5620
52
250
493
5254
138
631
334
4120
Inpatient Visit
IP [9201]
IP [9201]
6.1e-01
6.0e-01
—
1.0e+50
2.0e+00
1.5e+00
9.5e-01
cases:8.50%
controls:4.80%
cases:3.89%
controls:2.18%
—
—
cases:1.77%
controls:0.00%
cases:1.24%
controls:0.18%
cases:7.52%
controls:1.73%
cases:14.83%
controls:6.31%
48
271
517
5375
22
123
544
5529
—
10
0
556
5652
7
10
557
5633
41
95
504
5409
70
300
402
4451
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
1.3e+00
1.6e+00
—
1.0e+50
—
2.2e+00
1.2e+00
cases:2.83%
controls:0.81%
cases:1.59%
controls:0.34%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.47%
controls:0.16%
cases:1.69%
controls:0.53%
16
46
549
5600
9
19
557
5633
—
7
0
559
5652
—
8
9
537
5495
8
25
464
4726
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
7.1e-01
6.6e-01
1.2e+00
—
1.5e+00
9.2e-01
1.2e+00
cases:12.92%
controls:6.80%
cases:6.54%
controls:3.50%
cases:1.77%
controls:0.51%
—
—
cases:2.13%
controls:0.46%
cases:7.89%
controls:3.31%
cases:25.64%
controls:9.58%
73
384
492
5262
37
198
529
5454
10
29
556
5623
—
12
26
552
5617
43
182
502
5322
121
455
351
4296
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
6.8e-01
5.3e-01
1.2e+00
—
1.1e+00
7.2e-01
8.2e-01
cases:17.52%
controls:9.71%
cases:10.07%
controls:6.16%
cases:2.83%
controls:0.88%
—
—
cases:2.48%
controls:0.87%
cases:12.11%
controls:6.30%
cases:32.84%
controls:17.79%
99
548
466
5098
57
348
509
5304
16
50
550
5602
—
14
49
550
5594
66
347
479
5157
155
845
317
3906
Stomatognathic treatment, demanding
SHA03 [2001310407]
SHA03 [2001310407]
9.5e-01
—
—
—
—
2.4e+00
2.5e+00
cases:1.59%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.16%
cases:6.57%
controls:0.55%
9
35
556
5611
—
—
—
—
10
9
535
5495
31
26
441
4725
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
1.5e+00
9.2e-01
—
—
—
2.0e+00
1.5e+00
cases:4.07%
controls:0.96%
cases:1.24%
controls:0.50%
—
—
—
—
—
—
cases:1.28%
controls:0.18%
cases:4.03%
controls:0.93%
23
54
542
5592
7
28
559
5624
—
—
—
7
10
538
5494
19
44
453
4707
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
1.0e+00
1.1e+00
6.5e-01
—
9.4e-01
9.7e-01
9.4e-01
cases:35.58%
controls:16.37%
cases:19.08%
controls:7.61%
cases:2.47%
controls:1.31%
—
—
cases:3.01%
controls:1.21%
cases:18.72%
controls:8.03%
cases:37.29%
controls:18.92%
201
924
364
4722
108
430
458
5222
14
74
552
5578
—
17
68
547
5575
102
442
443
5062
176
899
296
3852
desloratadine; oral
R06AX27 [21603526]
R06AX27 [21603526]
7.4e-01
1.1e+00
8.9e-01
—
1.3e+00
9.5e-01
8.6e-01
cases:13.81%
controls:7.12%
cases:9.36%
controls:3.41%
cases:1.41%
controls:0.58%
—
—
cases:2.13%
controls:0.58%
cases:10.09%
controls:4.14%
cases:17.16%
controls:8.08%
78
402
487
5244
53
193
513
5459
8
33
558
5619
—
12
33
552
5610
55
228
490
5276
81
384
391
4367
tranexamic acid; oral, parenteral
B02AA02 [21601036]
B02AA02 [21601036]
1.0e+00
1.2e+00
-1.0e+50
—
—
1.7e+00
1.0e+00
cases:6.19%
controls:2.30%
cases:2.30%
controls:0.71%
cases:0.00%
controls:0.16%
—
—
—
—
cases:3.49%
controls:0.65%
cases:6.57%
controls:2.53%
35
130
530
5516
13
40
553
5612
0
9
566
5643
—
—
19
36
526
5468
31
120
441
4631
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
Z03.89 [2000503757]
9.6e-01
1.7e+00
—
—
—
1.3e+00
9.1e-01
cases:4.42%
controls:1.74%
cases:2.83%
controls:0.53%
—
—
—
—
—
—
cases:2.39%
controls:0.64%
cases:4.24%
controls:1.75%
25
98
540
5548
16
30
550
5622
—
—
—
13
35
532
5469
20
83
452
4668
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
6.9e-01
8.9e-01
1.4e+00
—
1.2e+00
1.2e+00
1.4e+00
cases:4.60%
controls:2.37%
cases:3.89%
controls:1.63%
cases:1.77%
controls:0.44%
—
—
cases:1.42%
controls:0.43%
cases:6.06%
controls:1.89%
cases:13.98%
controls:3.83%
26
134
539
5512
22
92
544
5560
10
25
556
5627
—
8
24
556
5619
33
104
512
5400
66
182
406
4569
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
8.6e-01
3.9e-01
2.1e+00
—
1.7e+00
8.9e-01
1.0e+00
cases:9.03%
controls:4.02%
cases:3.36%
controls:2.30%
cases:1.59%
controls:0.19%
—
—
cases:0.89%
controls:0.16%
cases:5.14%
controls:2.18%
cases:15.68%
controls:6.17%
51
227
514
5419
19
130
547
5522
9
11
557
5641
—
5
9
559
5634
28
120
517
5384
74
293
398
4458
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
1.2e+00
9.9e-01
1.1e+00
—
1.3e+00
1.2e+00
1.5e+00
cases:6.90%
controls:2.20%
cases:3.00%
controls:1.13%
cases:1.06%
controls:0.37%
—
—
cases:1.24%
controls:0.34%
cases:3.67%
controls:1.09%
cases:9.11%
controls:2.25%
39
124
526
5522
17
64
549
5588
6
21
560
5631
—
7
19
557
5624
20
60
525
5444
43
107
429
4644
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
4.8e-01
5.4e-01
1.2e+00
—
1.1e+00
5.9e-01
9.7e-01
cases:13.27%
controls:8.66%
cases:10.95%
controls:6.69%
cases:5.12%
controls:1.65%
—
—
cases:3.72%
controls:1.24%
cases:11.74%
controls:6.85%
cases:27.12%
controls:12.38%
75
489
490
5157
62
378
504
5274
29
93
537
5559
—
21
70
543
5573
64
377
481
5127
128
588
344
4163
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
1.1e+00
1.2e+00
—
—
2.1e+00
1.9e+00
1.9e+00
cases:2.65%
controls:0.89%
cases:1.41%
controls:0.44%
—
—
—
—
cases:0.89%
controls:0.11%
cases:2.02%
controls:0.31%
cases:4.03%
controls:0.65%
15
50
550
5596
8
25
558
5627
—
—
5
6
559
5637
11
17
534
5487
19
31
453
4720
Primary arthrosis of other joints
M19.0 [45601353]
M19.0 [45601353]
1.2e+00
1.6e+00
—
—
—
2.0e+00
1.6e+00
cases:2.30%
controls:0.71%
cases:1.24%
controls:0.25%
—
—
—
—
—
—
cases:1.65%
controls:0.22%
cases:4.03%
controls:0.82%
13
40
552
5606
7
14
559
5638
—
—
—
9
12
536
5492
19
39
453
4712
Allergy, unspecified
T78.4 [45580373]
T78.4 [45580373]
1.2e+00
1.4e+00
—
—
—
2.0e+00
1.7e+00
cases:2.48%
controls:0.74%
cases:1.06%
controls:0.27%
—
—
—
—
—
—
cases:1.65%
controls:0.24%
cases:3.18%
controls:0.61%
14
42
551
5604
6
15
560
5637
—
—
—
9
13
536
5491
15
29
457
4722
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
9.4e-01
1.4e+00
—
—
-1.0e+50
1.3e+00
1.2e+00
cases:4.96%
controls:2.00%
cases:2.65%
controls:0.67%
—
—
—
—
cases:0.00%
controls:0.09%
cases:2.20%
controls:0.64%
cases:8.05%
controls:2.48%
28
113
537
5533
15
38
551
5614
—
—
0
5
564
5638
12
35
533
5469
38
118
434
4633
naproxen; oral, rectal
M01AE02 [21603968]
M01AE02 [21603968]
8.2e-01
9.4e-01
1.3e+00
—
1.6e+00
7.6e-01
6.5e-01
cases:23.36%
controls:11.81%
cases:10.42%
controls:4.33%
cases:1.41%
controls:0.41%
—
—
cases:2.30%
controls:0.46%
cases:9.17%
controls:4.51%
cases:19.92%
controls:11.49%
132
667
433
4979
59
245
507
5407
8
23
558
5629
—
13
26
551
5617
50
248
495
5256
94
546
378
4205
naproxcinod
M01AE18 [40254094]
M01AE18 [40254094]
8.2e-01
9.4e-01
1.3e+00
—
1.6e+00
7.6e-01
6.5e-01
cases:23.36%
controls:11.81%
cases:10.42%
controls:4.33%
cases:1.41%
controls:0.41%
—
—
cases:2.30%
controls:0.46%
cases:9.17%
controls:4.51%
cases:19.92%
controls:11.49%
132
667
433
4979
59
245
507
5407
8
23
558
5629
—
13
26
551
5617
50
248
495
5256
94
546
378
4205
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
6.2e-01
8.5e-01
1.6e+00
2.3e+00
1.1e+00
8.2e-01
9.0e-01
cases:16.81%
controls:9.81%
cases:8.83%
controls:3.96%
cases:2.47%
controls:0.51%
cases:0.88%
controls:0.09%
cases:1.77%
controls:0.62%
cases:9.91%
controls:4.61%
cases:30.51%
controls:15.09%
95
554
470
5092
50
224
516
5428
14
29
552
5623
5
5
561
5647
10
35
554
5608
54
254
491
5250
144
717
328
4034
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
6.6e-01
7.6e-01
2.3e+00
—
2.2e+00
1.0e+00
9.3e-01
cases:7.96%
controls:4.27%
cases:2.65%
controls:1.26%
cases:0.88%
controls:0.09%
—
—
cases:1.06%
controls:0.12%
cases:3.12%
controls:1.14%
cases:10.17%
controls:4.29%
45
241
520
5405
15
71
551
5581
5
5
561
5647
—
6
7
558
5636
17
63
528
5441
48
204
424
4547
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
7.3e-01
3.5e-01
1.3e+00
—
1.9e+00
9.4e-01
1.1e+00
cases:11.33%
controls:5.79%
cases:4.42%
controls:3.17%
cases:1.06%
controls:0.28%
—
—
cases:1.60%
controls:0.23%
cases:6.97%
controls:2.85%
cases:25.00%
controls:9.60%
64
327
501
5319
25
179
541
5473
6
16
560
5636
—
9
13
555
5630
38
157
507
5347
118
456
354
4295
Prick test
37968009 [4242723]
37968009 [4242723]
1.3e+00
1.8e+00
—
—
—
1.2e+00
1.6e+00
cases:3.72%
controls:1.04%
cases:1.41%
controls:0.23%
—
—
—
—
—
—
cases:0.92%
controls:0.27%
cases:3.39%
controls:0.69%
21
59
544
5587
8
13
558
5639
—
—
—
5
15
540
5489
16
33
456
4718
ranitidine bismuth citrate; oral
A02BA07 [21600088]
A02BA07 [21600088]
1.0e+00
2.3e+00
—
—
—
1.8e+00
1.4e+00
cases:3.36%
controls:1.24%
cases:1.59%
controls:0.16%
—
—
—
—
—
—
cases:0.92%
controls:0.15%
cases:3.18%
controls:0.84%
19
70
546
5576
9
9
557
5643
—
—
—
5
8
540
5496
15
40
457
4711
ranitidine; oral, parenteral
A02BA02 [21600083]
A02BA02 [21600083]
1.0e+00
2.3e+00
—
—
—
1.8e+00
1.4e+00
cases:3.36%
controls:1.24%
cases:1.59%
controls:0.16%
—
—
—
—
—
—
cases:0.92%
controls:0.15%
cases:3.18%
controls:0.84%
19
70
546
5576
9
9
557
5643
—
—
—
5
8
540
5496
15
40
457
4711
melatonin; oral
N05CH01 [21604659]
N05CH01 [21604659]
1.1e+00
1.3e+00
—
—
1.2e+00
1.1e+00
1.2e+00
cases:6.55%
controls:2.21%
cases:4.59%
controls:1.34%
—
—
—
—
cases:0.89%
controls:0.27%
cases:4.77%
controls:1.62%
cases:13.14%
controls:4.46%
37
125
528
5521
26
76
540
5576
—
—
5
15
559
5628
26
89
519
5415
62
212
410
4539
Temporomandibular joint-pain-dysfunction syndrome
K07.65 [2000502796]
K07.65 [2000502796]
—
—
—
—
—
2.5e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.09%
cases:1.27%
controls:0.15%
—
—
—
—
—
6
5
539
5499
6
7
466
4744
clobetasol
D07AD01 [21602141]
D07AD01 [21602141]
8.3e-01
1.2e+00
—
—
—
1.2e+00
1.5e+00
cases:4.96%
controls:2.23%
cases:3.00%
controls:0.96%
—
—
—
—
—
—
cases:3.12%
controls:0.96%
cases:10.17%
controls:2.53%
28
126
537
5520
17
54
549
5598
—
—
—
17
53
528
5451
48
120
424
4631
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.8e-01
4.6e-01
1.0e+00
1.9e+00
8.7e-01
4.4e-01
2.9e-01
cases:30.27%
controls:26.53%
cases:28.09%
controls:19.83%
cases:10.07%
controls:3.95%
cases:1.94%
controls:0.30%
cases:9.04%
controls:3.99%
cases:29.91%
controls:21.58%
cases:53.39%
controls:46.22%
171
1498
394
4148
159
1121
407
4531
57
223
509
5429
11
17
555
5635
51
225
513
5418
163
1188
382
4316
252
2196
220
2555
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
7.3e-01
9.3e-01
2.2e+00
—
1.1e+00
5.6e-01
8.3e-01
cases:9.03%
controls:4.57%
cases:5.65%
controls:2.32%
cases:1.94%
controls:0.23%
—
—
cases:1.06%
controls:0.37%
cases:3.85%
controls:2.23%
cases:13.77%
controls:6.52%
51
258
514
5388
32
131
534
5521
11
13
555
5639
—
6
21
558
5622
21
123
524
5381
65
310
407
4441
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
1.8e+00
1.8e+00
—
—
—
1.5e+00
1.1e+00
cases:3.54%
controls:0.60%
cases:1.94%
controls:0.34%
—
—
—
—
—
—
cases:1.28%
controls:0.29%
cases:2.97%
controls:1.05%
20
34
545
5612
11
19
555
5633
—
—
—
7
16
538
5488
14
50
458
4701
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
1.2e+00
1.6e+00
—
—
—
2.1e+00
1.4e+00
cases:2.83%
controls:0.90%
cases:1.06%
controls:0.21%
—
—
—
—
—
—
cases:1.83%
controls:0.24%
cases:2.97%
controls:0.76%
16
51
549
5595
6
12
560
5640
—
—
—
10
13
535
5491
14
36
458
4715
Dorsalgia, unspecified
M54.9 [45538791]
M54.9 [45538791]
1.2e+00
1.8e+00
—
—
—
1.6e+00
8.5e-01
cases:3.89%
controls:1.24%
cases:2.30%
controls:0.37%
—
—
—
—
—
—
cases:2.02%
controls:0.42%
cases:3.18%
controls:1.39%
22
70
543
5576
13
21
553
5631
—
—
—
11
23
534
5481
15
66
457
4685
Gastroenterology
10 [38004455]
10 [38004455]
8.3e-01
1.2e+00
9.6e-01
—
—
1.4e+00
1.2e+00
cases:10.44%
controls:4.84%
cases:6.71%
controls:2.16%
cases:1.06%
controls:0.41%
—
—
—
—
cases:6.42%
controls:1.74%
cases:15.68%
controls:5.20%
59
273
506
5373
38
122
528
5530
6
23
560
5629
—
—
35
96
510
5408
74
247
398
4504
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
6.1e-01
7.1e-01
—
—
2.5e+00
8.5e-01
6.3e-01
cases:8.50%
controls:4.80%
cases:3.89%
controls:1.95%
—
—
—
—
cases:1.06%
controls:0.09%
cases:4.04%
controls:1.76%
cases:11.23%
controls:6.34%
48
271
517
5375
22
110
544
5542
—
—
6
5
558
5638
22
97
523
5407
53
301
419
4450
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.4e+00
2.1e+00
—
—
—
1.5e+00
1.1e+00
cases:4.96%
controls:1.31%
cases:2.30%
controls:0.28%
—
—
—
—
—
—
cases:1.28%
controls:0.29%
cases:3.39%
controls:1.16%
28
74
537
5572
13
16
553
5636
—
—
—
7
16
538
5488
16
55
456
4696
Nausea and vomiting
R11 [45539317]
R11 [45539317]
1.1e+00
—
—
—
—
2.2e+00
1.2e+00
cases:2.83%
controls:0.94%
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.22%
cases:4.24%
controls:1.33%
16
53
549
5593
—
—
—
—
11
12
534
5492
20
63
452
4688
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
4.2e-01
7.5e-01
1.1e+00
—
8.3e-01
7.5e-01
6.3e-01
cases:38.41%
controls:29.10%
cases:22.08%
controls:11.80%
cases:5.30%
controls:1.80%
—
—
cases:4.61%
controls:2.06%
cases:20.00%
controls:10.52%
cases:41.31%
controls:27.22%
217
1643
348
4003
125
667
441
4985
30
102
536
5550
—
26
116
538
5527
109
579
436
4925
195
1293
277
3458
Remote contact by phone
ZYC01 [2001311579]
ZYC01 [2001311579]
1.2e+00
2.1e+00
—
—
—
—
1.2e+00
cases:2.12%
controls:0.62%
cases:1.24%
controls:0.16%
—
—
—
—
—
—
—
—
cases:3.39%
controls:1.05%
12
35
553
5611
7
9
559
5643
—
—
—
—
16
50
456
4701
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
9.2e-01
6.7e-01
1.6e+00
—
—
8.1e-01
1.1e+00
cases:9.56%
controls:4.06%
cases:4.59%
controls:2.41%
cases:1.41%
controls:0.28%
—
—
—
—
cases:4.40%
controls:2.00%
cases:17.80%
controls:6.42%
54
229
511
5417
26
136
540
5516
8
16
558
5636
—
—
24
110
521
5394
84
305
388
4446
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
1.8e-01
3.0e-01
—
—
2.4e+00
1.3e+00
7.9e-01
cases:4.60%
controls:3.88%
cases:2.12%
controls:1.57%
—
—
—
—
cases:1.42%
controls:0.12%
cases:5.32%
controls:1.56%
cases:9.75%
controls:4.69%
26
219
539
5427
12
89
554
5563
—
—
8
7
556
5636
29
86
516
5418
46
223
426
4528
Vascular Surgery
77 [38004496]
77 [38004496]
6.2e-01
1.7e+00
—
1.0e+50
—
1.9e+00
9.1e-01
cases:3.54%
controls:1.93%
cases:3.71%
controls:0.71%
—
—
cases:1.24%
controls:0.00%
—
—
cases:4.04%
controls:0.64%
cases:5.08%
controls:2.10%
20
109
545
5537
21
40
545
5612
—
7
0
559
5652
—
22
35
523
5469
24
100
448
4651
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.5e-01
3.4e-01
8.6e-01
2.2e+00
6.8e-01
3.5e-01
2.4e-01
cases:44.42%
controls:40.75%
cases:47.70%
controls:39.40%
cases:24.03%
controls:11.80%
cases:6.01%
controls:0.67%
cases:19.68%
controls:11.02%
cases:51.38%
controls:42.73%
cases:72.88%
controls:67.92%
251
2301
314
3345
270
2227
296
3425
136
667
430
4985
34
38
532
5614
111
622
453
5021
280
2352
265
3152
344
3227
128
1524
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
6.9e-01
6.7e-01
8.1e-01
—
1.3e+00
6.7e-01
3.7e-01
cases:57.88%
controls:40.90%
cases:31.63%
controls:19.21%
cases:5.83%
controls:2.67%
—
—
cases:7.62%
controls:2.27%
cases:31.74%
controls:19.20%
cases:52.33%
controls:43.21%
327
2309
238
3337
179
1086
387
4566
33
151
533
5501
—
43
128
521
5515
173
1057
372
4447
247
2053
225
2698
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
6.9e-01
6.7e-01
8.1e-01
—
1.3e+00
6.7e-01
3.7e-01
cases:57.88%
controls:40.90%
cases:31.63%
controls:19.21%
cases:5.83%
controls:2.67%
—
—
cases:7.62%
controls:2.27%
cases:31.74%
controls:19.20%
cases:52.33%
controls:43.21%
327
2309
238
3337
179
1086
387
4566
33
151
533
5501
—
43
128
521
5515
173
1057
372
4447
247
2053
225
2698
Complicated migraine
G43.3 [45576576]
G43.3 [45576576]
1.4e+00
1.3e+00
—
—
—
1.7e+00
1.3e+00
cases:1.77%
controls:0.44%
cases:1.59%
controls:0.42%
—
—
—
—
—
—
cases:1.83%
controls:0.33%
cases:2.97%
controls:0.80%
10
25
555
5621
9
24
557
5628
—
—
—
10
18
535
5486
14
38
458
4713
Shoulder symptom/complaint
L08 [2002000632]
L08 [2002000632]
1.2e+00
1.2e+00
—
—
—
1.1e+00
9.9e-01
cases:5.66%
controls:1.86%
cases:2.65%
controls:0.80%
—
—
—
—
—
—
cases:2.39%
controls:0.82%
cases:9.11%
controls:3.58%
32
105
533
5541
15
45
551
5607
—
—
—
13
45
532
5459
43
170
429
4581
Pain, unspecified
R52.9 [45544151]
R52.9 [45544151]
1.3e+00
1.3e+00
—
—
—
1.7e+00
1.5e+00
cases:2.83%
controls:0.81%
cases:1.24%
controls:0.35%
—
—
—
—
—
—
cases:1.65%
controls:0.31%
cases:6.36%
controls:1.52%
16
46
549
5600
7
20
559
5632
—
—
—
9
17
536
5487
30
72
442
4679
Pain in thoracic spine
M54.6 [45606247]
M54.6 [45606247]
1.1e+00
2.0e+00
—
—
—
1.2e+00
1.3e+00
cases:2.48%
controls:0.81%
cases:1.94%
controls:0.27%
—
—
—
—
—
—
cases:1.10%
controls:0.33%
cases:4.45%
controls:1.26%
14
46
551
5600
11
15
555
5637
—
—
—
6
18
539
5486
21
60
451
4691
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
F32.11 [2000501981]
2.2e+00
—
—
—
—
—
2.2e+00
cases:1.77%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.32%
10
11
555
5635
—
—
—
—
—
13
15
459
4736
ENMG
XA402 [2001300405]
XA402 [2001300405]
2.1e+00
—
—
—
—
—
2.3e+00
cases:1.95%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.13%
11
14
554
5632
—
—
—
—
—
6
6
466
4745
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
2.1e+00
—
—
—
—
—
2.3e+00
cases:3.72%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:3.18%
controls:0.34%
21
26
544
5620
—
—
—
—
—
15
16
457
4735
Functional dyspepsia
K30 [45591584]
K30 [45591584]
1.3e+00
2.0e+00
—
—
—
1.2e+00
1.1e+00
cases:4.42%
controls:1.26%
cases:2.65%
controls:0.35%
—
—
—
—
—
—
cases:1.28%
controls:0.40%
cases:4.66%
controls:1.66%
25
71
540
5575
15
20
551
5632
—
—
—
7
22
538
5482
22
79
450
4672
Muscle pain
L18 [2002000642]
L18 [2002000642]
1.4e+00
—
—
—
—
2.3e+00
2.1e+00
cases:1.42%
controls:0.35%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
cases:2.12%
controls:0.27%
8
20
557
5626
—
—
—
—
6
6
539
5498
10
13
462
4738
Facial pain NOS
R51.81 [2000503604]
R51.81 [2000503604]
2.2e+00
—
—
—
—
2.3e+00
2.2e+00
cases:1.59%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.09%
cases:1.27%
controls:0.15%
9
10
556
5636
—
—
—
—
5
5
540
5499
6
7
466
4744
Psychiatric treatment plan, permanent discontinuation
ICC04 [2001304105]
ICC04 [2001304105]
2.1e+00
2.3e+00
—
—
—
—
1.4e+00
cases:1.24%
controls:0.16%
cases:1.06%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.27%
7
9
558
5637
6
6
560
5646
—
—
—
—
5
13
467
4738
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
9.1e-01
1.5e+00
—
—
—
1.4e+00
1.5e+00
cases:2.48%
controls:1.01%
cases:2.30%
controls:0.53%
—
—
—
—
—
—
cases:1.83%
controls:0.47%
cases:5.93%
controls:1.37%
14
57
551
5589
13
30
553
5622
—
—
—
10
26
535
5478
28
65
444
4686
Acute pain
R52.0 [45573031]
R52.0 [45573031]
1.3e+00
—
—
—
—
2.7e+00
1.7e+00
cases:1.42%
controls:0.41%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.09%
cases:2.33%
controls:0.44%
8
23
557
5623
—
—
—
—
7
5
538
5499
11
21
461
4730
Doppler ultrasound examination of heart
FM1DE [2001303299]
FM1DE [2001303299]
8.9e-01
1.4e+00
—
—
—
2.7e+00
1.6e+00
cases:2.30%
controls:0.96%
cases:1.06%
controls:0.27%
—
—
—
—
—
—
cases:3.30%
controls:0.24%
cases:4.66%
controls:0.95%
13
54
552
5592
6
15
560
5637
—
—
—
18
13
527
5491
22
45
450
4706
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
8.3e-01
1.7e+00
—
—
—
2.4e+00
1.9e+00
cases:2.12%
controls:0.94%
cases:1.24%
controls:0.23%
—
—
—
—
—
—
cases:1.83%
controls:0.16%
cases:4.66%
controls:0.76%
12
53
553
5593
7
13
559
5639
—
—
—
10
9
535
5495
22
36
450
4715
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
7.9e-01
8.8e-01
1.5e+00
—
1.9e+00
1.9e-01
7.5e-01
cases:7.43%
controls:3.51%
cases:3.71%
controls:1.57%
cases:1.24%
controls:0.28%
—
—
cases:1.24%
controls:0.19%
cases:2.02%
controls:1.67%
cases:6.36%
controls:3.09%
42
198
523
5448
21
89
545
5563
7
16
559
5636
—
7
11
557
5632
11
92
534
5412
30
147
442
4604
Eating disorder, unspecified
F50.9 [45547713]
F50.9 [45547713]
2.1e+00
—
—
—
—
—
2.2e+00
cases:1.59%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.15%
9
11
556
5635
—
—
—
—
—
6
7
466
4744
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
7.0e-01
7.2e-01
1.4e+00
—
2.6e-01
6.3e-01
8.4e-01
cases:27.61%
controls:15.96%
cases:16.25%
controls:8.62%
cases:4.06%
controls:1.04%
—
—
cases:1.42%
controls:1.10%
cases:14.68%
controls:8.41%
cases:43.64%
controls:25.13%
156
901
409
4745
92
487
474
5165
23
59
543
5593
—
8
62
556
5581
80
463
465
5041
206
1194
266
3557
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.2e+00
8.2e-01
7.8e-01
—
9.5e-01
1.2e+00
1.0e+00
cases:12.39%
controls:4.02%
cases:6.18%
controls:2.81%
cases:1.77%
controls:0.81%
—
—
cases:2.13%
controls:0.83%
cases:8.07%
controls:2.60%
cases:11.23%
controls:4.31%
70
227
495
5419
35
159
531
5493
10
46
556
5606
—
12
47
552
5596
44
143
501
5361
53
205
419
4546
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
1.3e+00
2.3e+00
—
—
—
—
1.9e+00
cases:1.59%
controls:0.43%
cases:1.06%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.32%
9
24
556
5622
6
6
560
5646
—
—
—
—
10
15
462
4736
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
ZXE13 [2001311404]
1.5e+00
—
—
—
—
—
2.8e+00
cases:3.19%
controls:0.76%
—
—
—
—
—
—
—
—
—
—
cases:6.36%
controls:0.42%
18
43
547
5603
—
—
—
—
—
30
20
442
4731
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
9.5e-01
9.3e-01
—
—
—
1.1e+00
1.2e+00
cases:6.90%
controls:2.78%
cases:3.18%
controls:1.27%
—
—
—
—
—
—
cases:4.04%
controls:1.34%
cases:11.02%
controls:3.56%
39
157
526
5489
18
72
548
5580
—
—
—
22
74
523
5430
52
169
420
4582
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
N02BE51 [21604348]
1.1e+00
9.5e-01
2.2e+00
—
—
6.6e-01
6.7e-01
cases:10.44%
controls:3.68%
cases:3.00%
controls:1.19%
cases:1.06%
controls:0.12%
—
—
—
—
cases:2.75%
controls:1.44%
cases:6.57%
controls:3.47%
59
208
506
5438
17
67
549
5585
6
7
560
5645
—
—
15
79
530
5425
31
165
441
4586
Knee symptom/complaint
L15 [2002000639]
L15 [2002000639]
7.2e-01
1.4e+00
—
—
1.6e+00
1.4e+00
7.2e-01
cases:6.55%
controls:3.29%
cases:3.36%
controls:0.85%
—
—
—
—
cases:0.89%
controls:0.18%
cases:4.04%
controls:1.05%
cases:7.42%
controls:3.77%
37
186
528
5460
19
48
547
5604
—
—
5
10
559
5633
22
58
523
5446
35
179
437
4572
Dislocation of patella
S83.0 [45598912]
S83.0 [45598912]
2.1e+00
2.2e+00
—
—
—
—
1.9e+00
cases:2.30%
controls:0.30%
cases:1.06%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.19%
13
17
552
5629
6
7
560
5645
—
—
—
—
6
9
466
4742
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
8.6e-01
8.9e-01
1.1e+00
—
1.7e+00
1.3e+00
1.2e+00
cases:10.80%
controls:4.89%
cases:5.30%
controls:2.25%
cases:1.06%
controls:0.35%
—
—
cases:1.24%
controls:0.23%
cases:6.61%
controls:1.94%
cases:16.53%
controls:5.75%
61
276
504
5370
30
127
536
5525
6
20
560
5632
—
7
13
557
5630
36
107
509
5397
78
273
394
4478
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
1.5e+00
2.3e+00
—
—
—
—
1.9e+00
cases:1.24%
controls:0.28%
cases:1.06%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.29%
7
16
558
5630
6
6
560
5646
—
—
—
—
9
14
463
4737
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
9.5e-01
9.0e-01
1.0e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:21.24%
controls:9.40%
cases:8.83%
controls:3.79%
cases:1.59%
controls:0.57%
—
—
cases:1.42%
controls:0.43%
cases:11.19%
controls:3.49%
cases:24.36%
controls:9.83%
120
531
445
5115
50
214
516
5438
9
32
557
5620
—
8
24
556
5619
61
192
484
5312
115
467
357
4284
Other difficulties with micturition
R39.1 [45534441]
R39.1 [45534441]
1.9e+00
-1.0e+50
—
—
—
—
2.3e+00
cases:1.24%
controls:0.19%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.13%
7
11
558
5635
0
6
566
5646
—
—
—
—
6
6
466
4745
Other cervical disc degeneration
M50.3 [45582167]
M50.3 [45582167]
1.8e+00
—
—
—
—
—
2.4e+00
cases:1.42%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:2.33%
controls:0.21%
8
14
557
5632
—
—
—
—
—
11
10
461
4741
Preparing and fitting the occlusal splint in the mouth
SHB00 [2001310410]
SHB00 [2001310410]
7.9e-01
1.3e+00
—
—
—
1.3e+00
1.5e+00
cases:4.07%
controls:1.90%
cases:2.47%
controls:0.65%
—
—
—
—
—
—
cases:3.12%
controls:0.89%
cases:12.71%
controls:3.01%
23
107
542
5539
14
37
552
5615
—
—
—
17
49
528
5455
60
143
412
4608
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
9.6e-01
8.8e-01
1.0e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:21.24%
controls:9.39%
cases:8.66%
controls:3.79%
cases:1.59%
controls:0.57%
—
—
cases:1.42%
controls:0.43%
cases:11.19%
controls:3.49%
cases:24.15%
controls:9.72%
120
530
445
5116
49
214
517
5438
9
32
557
5620
—
8
24
556
5619
61
192
484
5312
114
462
358
4289
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7818-8 [3008230]
1.2e+00
1.0e+00
—
—
—
1.8e+00
1.2e+00
cases:3.72%
controls:1.20%
cases:1.24%
controls:0.44%
—
—
—
—
—
—
cases:1.28%
controls:0.22%
cases:4.87%
controls:1.47%
21
68
544
5578
7
25
559
5627
—
—
—
7
12
538
5492
23
70
449
4681
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.9e-01
4.6e-01
1.8e+00
—
2.2e+00
9.6e-01
9.6e-01
cases:8.32%
controls:5.77%
cases:3.71%
controls:2.37%
cases:1.06%
controls:0.18%
—
—
cases:2.13%
controls:0.23%
cases:5.87%
controls:2.33%
cases:15.89%
controls:6.76%
47
326
518
5320
21
134
545
5518
6
10
560
5642
—
12
13
552
5630
32
128
513
5376
75
321
397
4430
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
8.7e-01
8.4e-01
1.2e+00
—
2.4e-01
6.4e-01
5.6e-01
cases:27.43%
controls:13.66%
cases:10.78%
controls:4.97%
cases:2.12%
controls:0.64%
—
—
cases:1.24%
controls:0.97%
cases:9.54%
controls:5.25%
cases:26.27%
controls:16.90%
155
771
410
4875
61
281
505
5371
12
36
554
5616
—
7
55
557
5588
52
289
493
5215
124
803
348
3948
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
9.7e-01
1.3e+00
—
—
—
1.1e+00
7.4e-01
cases:8.32%
controls:3.31%
cases:3.00%
controls:0.87%
—
—
—
—
—
—
cases:3.12%
controls:1.02%
cases:7.20%
controls:3.58%
47
187
518
5459
17
49
549
5603
—
—
—
17
56
528
5448
34
170
438
4581
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.0e+00
1.0e+00
—
—
—
1.2e+00
8.5e-01
cases:5.49%
controls:2.00%
cases:2.83%
controls:1.03%
—
—
—
—
—
—
cases:3.67%
controls:1.14%
cases:7.42%
controls:3.33%
31
113
534
5533
16
58
550
5594
—
—
—
20
63
525
5441
35
158
437
4593
Catheterisation of bladder
TKC20 [2001306020]
TKC20 [2001306020]
1.8e+00
1.6e+00
—
—
—
2.3e+00
—
cases:1.95%
controls:0.34%
cases:0.88%
controls:0.18%
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
11
19
554
5627
5
10
561
5642
—
—
—
6
6
539
5498
—
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
6.2e-01
9.8e-01
2.0e+00
—
1.4e+00
1.3e+00
1.2e+00
cases:11.15%
controls:6.34%
cases:4.42%
controls:1.70%
cases:0.88%
controls:0.12%
—
—
cases:1.06%
controls:0.27%
cases:5.14%
controls:1.42%
cases:12.50%
controls:4.27%
63
358
502
5288
25
96
541
5556
5
7
561
5645
—
6
15
558
5628
28
78
517
5426
59
203
413
4548
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
8.1e-01
1.0e+00
—
—
—
2.2e+00
1.9e+00
cases:1.42%
controls:0.64%
cases:1.06%
controls:0.39%
—
—
—
—
—
—
cases:2.02%
controls:0.24%
cases:4.45%
controls:0.67%
8
36
557
5610
6
22
560
5630
—
—
—
11
13
534
5491
21
32
451
4719
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
8.2e-01
7.4e-01
—
—
—
1.8e+00
2.3e+00
cases:1.95%
controls:0.87%
cases:0.88%
controls:0.42%
—
—
—
—
—
—
cases:2.20%
controls:0.38%
cases:6.78%
controls:0.72%
11
49
554
5597
5
24
561
5628
—
—
—
12
21
533
5483
32
34
440
4717
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
9.6e-01
8.5e-01
—
—
—
1.5e+00
1.6e+00
cases:8.14%
controls:3.28%
cases:2.12%
controls:0.92%
—
—
—
—
—
—
cases:2.75%
controls:0.65%
cases:8.69%
controls:1.81%
46
185
519
5461
12
52
554
5600
—
—
—
15
36
530
5468
41
86
431
4665
Personality disorder, unspecified
F60.9 [45538076]
F60.9 [45538076]
2.0e+00
—
—
—
—
—
2.0e+00
cases:1.06%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.17%
6
8
559
5638
—
—
—
—
—
6
8
466
4743
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
5.6e-01
1.9e-01
1.3e+00
—
1.6e+00
9.5e-01
9.4e-01
cases:11.15%
controls:6.71%
cases:4.42%
controls:3.70%
cases:1.94%
controls:0.55%
—
—
cases:2.30%
controls:0.50%
cases:8.81%
controls:3.62%
cases:20.97%
controls:9.37%
63
379
502
5267
25
209
541
5443
11
31
555
5621
—
13
28
551
5615
48
199
497
5305
99
445
373
4306
Trochanteric bursitis
M70.6 [45606304]
M70.6 [45606304]
1.1e+00
2.0e+00
-1.0e+50
—
—
1.3e+00
9.3e-01
cases:3.54%
controls:1.22%
cases:2.12%
controls:0.30%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.47%
controls:0.40%
cases:4.03%
controls:1.62%
20
69
545
5577
12
17
554
5635
0
6
566
5646
—
—
8
22
537
5482
19
77
453
4674
Primary dysmenorrhoea
N94.4 [45606521]
N94.4 [45606521]
1.7e+00
2.3e+00
—
—
—
—
1.1e+00
cases:1.95%
controls:0.37%
cases:1.24%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.51%
11
21
554
5625
7
7
559
5645
—
—
—
—
7
24
465
4727
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
9.9e-01
1.0e+00
-1.0e+50
—
—
1.9e+00
1.1e+00
cases:4.07%
controls:1.56%
cases:1.24%
controls:0.44%
cases:0.00%
controls:0.12%
—
—
—
—
cases:2.57%
controls:0.38%
cases:4.45%
controls:1.58%
23
88
542
5558
7
25
559
5627
0
7
566
5645
—
—
14
21
531
5483
21
75
451
4676
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
7.0e-01
6.7e-01
5.8e-02
—
1.1e+00
7.5e-01
7.4e-01
cases:47.08%
controls:30.73%
cases:16.96%
controls:9.48%
cases:1.24%
controls:1.17%
—
—
cases:3.37%
controls:1.13%
cases:16.33%
controls:8.43%
cases:43.64%
controls:26.92%
266
1735
299
3911
96
536
470
5116
7
66
559
5586
—
19
64
545
5579
89
464
456
5040
206
1279
266
3472
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
6.9e-01
1.1e+00
—
—
—
1.6e+00
1.3e+00
cases:4.42%
controls:2.27%
cases:2.30%
controls:0.80%
—
—
—
—
—
—
cases:2.94%
controls:0.64%
cases:9.32%
controls:2.63%
25
128
540
5518
13
45
553
5607
—
—
—
16
35
529
5469
44
125
428
4626
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
N02CC01 [21604376]
9.5e-01
9.9e-01
8.6e-01
—
6.6e-01
8.6e-01
1.2e+00
cases:12.57%
controls:5.24%
cases:7.24%
controls:2.83%
cases:1.41%
controls:0.60%
—
—
cases:1.60%
controls:0.83%
cases:6.97%
controls:3.09%
cases:16.10%
controls:5.70%
71
296
494
5350
41
160
525
5492
8
34
558
5618
—
9
47
555
5596
38
170
507
5334
76
271
396
4480
antibiotics in combination with corticosteroids
D01AA20 [21601918]
D01AA20 [21601918]
1.0e+00
1.1e+00
—
—
—
1.5e+00
1.4e+00
cases:3.54%
controls:1.33%
cases:1.24%
controls:0.42%
—
—
—
—
—
—
cases:1.83%
controls:0.40%
cases:4.45%
controls:1.14%
20
75
545
5571
7
24
559
5628
—
—
—
10
22
535
5482
21
54
451
4697
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
6.2e-01
9.3e-01
1.3e+00
—
1.5e+00
1.1e+00
1.2e+00
cases:11.33%
controls:6.45%
cases:6.36%
controls:2.60%
cases:1.24%
controls:0.35%
—
—
cases:1.42%
controls:0.32%
cases:7.71%
controls:2.58%
cases:21.61%
controls:7.39%
64
364
501
5282
36
147
530
5505
7
20
559
5632
—
8
18
556
5625
42
142
503
5362
102
351
370
4400
Nutritional therapy
R4190 [2001310243]
R4190 [2001310243]
—
—
—
—
—
2.1e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.16%
cases:3.18%
controls:0.51%
—
—
—
—
—
7
9
538
5495
15
24
457
4727
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
3.7e-01
1.1e+00
2.2e+00
—
—
5.2e-01
6.9e-01
cases:3.36%
controls:2.36%
cases:3.18%
controls:1.10%
cases:1.06%
controls:0.12%
—
—
—
—
cases:2.39%
controls:1.44%
cases:9.32%
controls:4.90%
19
133
546
5513
18
62
548
5590
6
7
560
5645
—
—
13
79
532
5425
44
233
428
4518
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
8.6e-01
1.0e+00
2.1e+00
—
1.3e+00
8.1e-01
1.2e+00
cases:11.15%
controls:5.07%
cases:4.06%
controls:1.50%
cases:0.88%
controls:0.11%
—
—
cases:0.89%
controls:0.25%
cases:4.04%
controls:1.84%
cases:16.10%
controls:5.26%
63
286
502
5360
23
85
543
5567
5
6
561
5646
—
5
14
559
5629
22
101
523
5403
76
250
396
4501
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
4.0e-01
1.2e+00
—
—
—
2.4e+00
1.5e+00
cases:1.24%
controls:0.83%
cases:1.06%
controls:0.34%
—
—
—
—
—
—
cases:2.75%
controls:0.25%
cases:4.45%
controls:1.01%
7
47
558
5599
6
19
560
5633
—
—
—
15
14
530
5490
21
48
451
4703
Special examination of mouth
SAA04 [2001310277]
SAA04 [2001310277]
1.1e+00
1.4e+00
—
—
—
2.1e+00
1.8e+00
cases:2.12%
controls:0.69%
cases:0.88%
controls:0.21%
—
—
—
—
—
—
cases:1.47%
controls:0.18%
cases:2.54%
controls:0.42%
12
39
553
5607
5
12
561
5640
—
—
—
8
10
537
5494
12
20
460
4731
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
390
2289
2.99
36.21
9.4
6.7
1.21
1.22
mmol/l
1.66
343
2017
352
2027
2.77
32.64
9.3
6.2
1.21
1.22
mmol/l
2.99
334
1902
150
593
3.03
27.89
2.4
2.1
337.91
380.28
nmol/l
2.00
136
563
425
2816
2.72
27.84
6.6
4.7
6.01
6.31
mmol/l
3.15
407
2583
260
1368
2.58
27.72
4.7
2.8
0.10
0.31
e6/l
4.22
198
941
286
1579
2.54
27.48
4.7
3.0
398.87
55.32
e6/l
0.57
227
1147
244
1250
2.60
27.45
6.2
4.1
97.05
95.20
%
0.62
239
1226
172
740
2.85
27.35
4.0
3.6
0.85
0.82
mmol/l
2.88
153
710
387
2479
2.56
26.71
3.9
2.6
75.34
73.65
nmol/l
0.59
363
2328
211
1043
2.57
25.18
3.1
2.6
6.51
8.73
e6/l
1.17
190
938
244
1292
2.49
25.13
2.4
2.1
138.01
197.95
u/l
0.53
232
1232
326
1970
2.42
24.97
2.7
1.9
97.08
98.13
pmol/l
0.18
191
1063
506
3772
3.10
24.56
9.3
7.1
75.76
77.18
u/l
0.28
487
3598
149
641
2.76
23.30
3.4
2.6
30.19
29.30
s
1.26
144
622
378
2497
2.37
22.83
5.9
5.9
10.16
10.46
umol/l
0.17
361
2373
65
170
4.16
22.67
6.7
4.4
3.07
3.43
g/l
1.63
59
165
445
3180
2.52
22.17
9.7
9.1
4.07
3.92
e9/l
0.71
401
2766
84
270
3.45
21.74
1.3
1.3
0.17
0.93
u/ml
—
10
13
167
786
2.55
21.62
4.3
2.6
4.80
3.82
e6/l
0.35
78
340
164
775
2.53
20.98
3.3
2.4
14.91
14.15
umol/l
0.67
154
725
314
1968
2.24
20.80
5.5
4.7
36.47
37.03
g/l
0.99
300
1888
142
629
2.64
20.74
3.1
2.4
24.56
23.18
%
0.59
133
587
227
1251
2.31
20.49
1.8
1.6
20.72
21.15
nmol/l
0.16
202
1108
102
383
3.00
20.34
7.2
8.3
0.77
0.86
mmol/l
0.09
77
316
185
943
2.39
19.92
3.0
2.6
81.55
93.08
ug/g
0.31
145
765
171
845
2.43
19.71
4.2
2.5
1.01
0.87
e6/l
0.21
87
398
149
693
2.53
19.57
3.2
2.3
2.44
2.43
g/l
0.09
138
644
299
1876
2.18
19.30
3.8
3.2
32.33
27.90
u/l
0.34
291
1802
120
506
2.71
19.22
1.4
1.3
205.85
273.68
u/ml
0.35
112
472
251
1495
2.16
18.24
3.5
2.4
52.57
59.12
u/l
1.16
238
1411
463
3506
2.37
18.05
6.4
4.1
610.33
1699.19
e6/l
—
6
47
363
2528
2.09
17.02
12.6
10.0
0.00
0.00
e9/l
0.25
296
2044
497
3938
2.48
16.55
5.6
4.1
9.24
9.17
mm/h
0.05
478
3749
172
912
2.24
16.45
2.5
3.2
766.24
755.35
ng/l
0.01
142
747
236
1419
2.09
16.32
4.0
2.2
2.38
2.62
mg/l
1.19
202
1240
265
1664
2.06
16.28
3.0
3.0
2.34
2.35
mmol/l
0.82
251
1555
198
1118
2.15
16.12
1.5
1.3
7.82
10.25
u/ml
0.20
78
446
400
2923
2.09
16.03
4.8
3.5
0.00
0.00
estimate
-0.00
90
592
20
6
34.40
15.82
1.1
1.8
—
—
—
0
0
28
24
12.18
15.70
1.1
1.0
108.17
101.25
%
0.61
12
16
114
515
2.50
15.65
12.2
7.5
105.11
104.65
mmol/l
0.49
114
515
207
1203
2.10
15.53
1.5
1.3
31.48
25.64
iu/ml
0.17
55
354
395
2905
2.04
15.14
4.8
3.4
0.00
7.38
estimate
1.08
92
615
392
2877
2.03
15.09
4.8
3.4
0.00
0.00
estimate
0.50
89
616
425
3241
2.05
14.31
5.2
3.3
68.15
70.18
ug/l
0.11
401
3107
26
24
11.27
14.12
1.1
1.0
101.70
108.19
%
—
10
16
208
1251
2.01
13.93
3.0
2.1
1.31
0.83
mg/l
0.57
154
945
91
397
2.52
13.35
1.4
1.3
12.95
31.29
au/ml
—
6
24
120
593
2.28
13.33
2.1
1.6
1090.50
1127.01
nmol/l
0.14
92
467
21
34
6.36
12.54
3.7
2.4
691.76
588.53
u/ml
0.12
21
34
95
436
2.40
12.46
2.6
2.3
13.48
18.31
au/ml
0.61
13
50
232
1500
1.89
12.21
3.7
3.0
15.94
56.80
ng/l
0.71
118
764
90
408
2.42
12.12
4.5
2.8
0.22
0.23
g/l
0.42
82
389
157
892
2.03
12.08
1.7
1.6
154687963.02
27945289.32
pmol/l
0.51
128
798
92
428
2.36
11.68
4.8
3.7
4.68
4.68
pmol/l
0.01
79
384
92
434
2.32
11.30
10.6
5.3
1.66
1.50
mmol/l
0.15
82
354
59
227
2.77
11.08
10.4
10.8
0.67
0.63
%
0.39
59
227
339
2515
1.79
11.02
3.4
2.7
—
—
estimate
—
0
0
576
5164
3.49
10.63
23.1
12.4
3.89
3.91
mmol/l
1.69
571
5059
70
300
2.51
10.60
1.8
1.6
—
—
—
0
0
140
799
1.98
10.48
2.7
3.0
742.78
228.35
ng/l
0.87
77
456
44
150
3.09
10.26
1.7
1.4
308.70
315.90
ug/g
0.07
20
80
111
587
2.09
10.23
6.5
6.5
1.13
1.10
mmol/l
0.39
106
548
58
232
2.66
10.11
10.6
10.6
1.12
1.27
%
0.52
58
232
98
498
2.16
10.01
2.8
2.5
32.47
31.48
u/l
0.09
83
414
19
36
5.42
9.69
1.2
1.1
0.31
0.30
g/l
0.23
13
31
57
231
2.62
9.68
10.8
10.7
94.00
94.33
%
0.12
57
231
73
333
2.36
9.64
5.3
4.2
61.66
71.08
ng/l
0.64
67
305
38
124
3.20
9.53
2.0
2.6
2.40
2.16
index
0.10
25
62
298
2196
1.70
9.35
4.3
3.2
0.03
0.03
estimate
0.02
79
517
29
81
3.71
9.21
1.1
1.2
—
23.80
—
0
5
61
266
2.44
8.90
2.0
1.9
—
—
—
0
0
51
204
2.64
8.89
1.3
1.2
—
17.64
—
0
11
69
321
2.30
8.70
2.7
3.7
1.22
1.22
mmol/l
0.04
54
274
521
4554
2.05
8.55
6.0
4.7
14.36
14.36
pmol/l
0.01
490
4302
225
1566
1.70
8.52
1.8
1.5
1.99
2.03
g/l
0.19
148
990
104
575
1.98
8.40
3.9
3.3
5.14
5.75
umol/l
0.31
88
491
48
193
2.62
8.29
1.2
1.3
—
15.43
—
0
35
48
193
2.62
8.29
1.2
1.3
—
3.29
—
0
20
187
1247
1.72
8.24
3.2
2.1
—
—
—
0
0
39
141
2.89
8.23
1.1
1.3
—
1.12
—
0
11
50
209
2.52
7.98
12.7
5.1
0.58
0.62
%
0.31
50
209
80
410
2.10
7.94
3.5
2.8
—
—
—
0
0
583
5382
3.39
7.84
22.4
12.0
18.64
19.72
mg/l
0.45
507
4286
63
297
2.25
7.70
8.8
4.6
1.83
1.21
mmol/l
0.81
53
214
170
1122
1.72
7.70
2.3
2.7
298.43
308.28
umol/l
0.74
157
1033
62
291
2.26
7.66
1.7
2.2
1.58
5.81
iu/ml
4.22
16
66
243
1766
1.63
7.57
1.5
1.5
0.69
2.07
u/ml
3.03
57
480
60
280
2.27
7.51
1.8
2.8
68.13
67.22
g/l
0.45
55
268
31
104
3.09
7.45
2.0
2.4
132.96
131.35
g/l
0.19
24
85
108
632
1.86
7.31
1.9
1.5
20.32
22.47
iu/l
0.29
87
540
50
221
2.38
7.09
1.8
2.7
80.55
110.49
ng/l
0.50
40
201
213
1523
1.62
6.96
4.6
3.5
0.00
0.00
estimate
0.80
89
590
233
1705
1.60
6.91
4.0
2.8
0.00
0.11
estimate
0.62
79
516
67
344
2.07
6.61
8.9
4.3
5.40
5.11
kpa
2.36
67
333
86
483
1.91
6.59
1.9
1.7
—
—
—
0
0
185
1299
1.61
6.43
3.7
3.2
1.02
1.02
kg/l
0.62
125
841
83
465
1.91
6.40
2.0
1.7
—
—
—
0
0
26
87
3.08
6.30
1.4
1.3
—
—
—
0
0
26
87
3.08
6.30
1.4
1.3
—
—
—
0
0
50
233
2.25
6.30
13.3
5.3
131.68
129.85
g/l
0.27
50
225
19
52
3.74
6.24
1.2
3.3
—
—
—
0
0
47
215
2.29
6.18
2.0
1.4
—
—
—
0
0
18
48
3.83
6.13
1.2
1.2
143.72
117.17
pmol/l
1.32
18
48
122
783
1.70
5.98
1.6
1.6
1.49
1.35
%
1.32
105
713
530
4808
1.84
5.69
4.5
4.0
5.55
5.64
mmol/l
0.99
490
4539
21
67
3.21
5.51
1.1
1.1
—
—
—
0
0
21
67
3.21
5.51
1.1
1.1
—
—
—
0
0
106
670
1.71
5.47
2.0
1.8
—
—
—
0
0
48
235
2.13
5.38
1.5
1.3
—
—
—
0
0
585
5522
2.89
5.35
14.4
10.1
24.01
24.39
u/l
0.23
573
5413
96
594
1.73
5.34
1.5
1.3
116.71
158.57
u/ml
0.38
41
244
19
59
3.29
5.21
1.1
3.2
571.57
516.20
e6/l
0.25
14
41
554
5126
1.98
5.17
7.4
5.6
1.63
1.77
mu/l
1.56
531
4917
21
70
3.07
5.15
1.1
1.1
—
—
—
0
0
529
4828
1.77
5.13
17.9
10.7
95.56
92.21
ml/min/173m2
3.71
496
4365
20
65
3.15
5.11
1.2
1.1
—
—
—
0
0
27
105
2.64
5.03
1.1
1.2
—
—
—
0
0
20
66
3.10
4.99
1.2
1.1
—
—
—
0
0
29
120
2.49
4.79
1.7
1.9
133.27
184.23
ug/l
0.52
23
110
21
74
2.90
4.70
1.1
1.1
—
—
—
0
0
90
568
1.69
4.65
2.7
2.2
4209.70
4774.21
u/l
0.08
29
233
69
405
1.79
4.60
1.7
1.6
295.00
320.20
mu/l
0.48
61
373
43
215
2.08
4.59
1.2
1.1
4.28
4.38
—
6
30
34
158
2.22
4.36
1.4
1.3
—
—
—
0
0
20
72
2.84
4.32
1.9
1.5
—
—
—
0
0
122
847
1.55
4.27
2.6
2.3
2.42
2.42
mmol/l
0.14
109
759
12
25
4.87
4.20
1.2
3.5
0.67
0.88
index
0.42
12
25
45
240
1.95
4.04
2.9
2.2
5.87
10.55
nmol/l
3.18
39
230
500
4574
1.54
3.91
5.1
4.9
35.67
37.35
mmol/mol
6.60
462
4391
39
201
2.01
3.87
1.5
1.5
0.27
0.39
nmol/l
1.63
31
173
434
3873
1.43
3.75
4.3
3.2
31.82
35.53
u/l
0.87
411
3737
21
84
2.55
3.75
3.1
3.7
3.78
3.81
mmol/l
0.10
21
84
115
812
1.51
3.71
2.4
2.0
—
—
—
0
0
9
16
5.69
3.67
1.1
1.0
—
—
—
0
0
9
16
5.69
3.67
3.7
2.1
142.87
120.56
ug/l
—
9
16
43
234
1.90
3.66
1.8
1.6
4.39
8.79
u/ml
—
8
64
22
93
2.42
3.52
1.7
1.4
—
—
—
0
0
49
282
1.80
3.52
1.7
1.6
8.38
10.49
u/l
0.63
37
228
17
63
2.75
3.51
1.2
1.3
—
—
—
0
0
58
352
1.72
3.48
3.1
2.2
72.57
76.23
ml/min/173m2
0.24
28
145
22
99
2.27
3.09
1.7
2.9
5.38
7.18
pmol/l
0.85
22
99
131
985
1.42
3.04
2.5
2.1
—
—
—
0
0
186
1490
1.36
2.95
3.3
3.1
7.73
8.02
mmol/l
0.32
165
1312
13
46
2.87
2.93
6.5
6.2
11.71
10.91
mg/l
0.24
13
40
18
76
2.41
2.92
1.4
1.7
—
—
—
0
0
37
210
1.81
2.81
1.8
1.6
—
—
—
0
0
14
55
2.58
2.63
1.4
1.6
—
—
—
0
0
216
1795
1.32
2.62
1.9
1.8
—
—
—
0
0
44
274
1.65
2.45
1.6
1.4
0.25
0.28
mg/l
0.06
16
115
22
111
2.02
2.38
1.4
1.6
—
—
—
0
0
164
1331
1.32
2.32
2.3
2.2
—
—
—
0
0
54
360
1.55
2.29
1.8
1.5
—
—
—
0
0
38
232
1.68
2.29
1.2
1.2
1.01
3.61
u/ml
1.61
25
144
24
127
1.93
2.29
1.4
1.6
—
—
—
0
0
13
53
2.48
2.29
1.4
1.3
—
—
—
0
0
8
23
3.51
2.27
1.0
1.0
—
—
—
0
0
14
60
2.36
2.23
1.2
1.6
—
—
—
0
0
11
41
2.71
2.21
1.0
1.0
1.13
1.05
ratio
—
6
36
11
41
2.71
2.21
1.1
1.1
—
—
—
0
0
13
54
2.44
2.21
1.4
1.3
—
—
—
0
0
6
14
4.32
2.15
1.7
2.9
4.85
4.53
kpa
—
6
14
6
14
4.32
2.15
1.7
2.9
11.98
10.97
kpa
—
6
14
14
288
0.47
2.10
1.1
1.2
0.84
0.89
g/l
0.57
14
288
26
146
1.82
2.10
4.4
4.1
1.68
1.62
%
0.13
26
138
20
365
0.53
2.09
1.5
1.4
93.97
251.92
miu/ml
—
10
188
173
1433
1.29
2.08
2.5
2.4
—
—
—
0
0
18
90
2.03
2.02
1.4
1.7
15346.73
16193.16
e6/l
0.02
11
64
178
1487
1.28
2.00
1.5
1.6
—
—
—
0
0
21
112
1.91
1.98
1.7
2.2
0.85
0.83
nmol/l
0.04
21
99
14
280
0.49
1.95
1.1
1.1
1.45
1.57
g/l
0.54
14
280
59
816
0.69
1.94
1.8
1.8
3.68
3.31
ratio
1.10
42
611
5
11
4.57
1.94
1.2
1.2
—
—
—
0
0
32
197
1.66
1.90
1.9
2.1
3.18
4.49
iu/l
0.58
15
79
9
34
2.67
1.87
1.1
1.1
—
—
—
0
0
6
17
3.55
1.84
1.0
3.1
214.17
191.82
u/l
—
6
17
27
161
1.71
1.81
1.2
1.2
—
—
—
0
0
9
35
2.59
1.80
1.1
1.7
—
—
—
0
0
53
732
0.70
1.74
1.6
1.6
1038.84
1007.72
mu/l
0.10
45
611
7
24
2.94
1.72
1.1
1.4
—
—
—
0
0
596
5864
2.24
1.72
32.4
18.8
268.84
264.85
e9/l
0.85
589
5782
27
164
1.68
1.71
1.6
1.4
215.06
183.31
u/ml
0.29
17
98
26
157
1.69
1.68
1.3
1.1
2.66
19.53
au/ml
—
8
43
10
42
2.40
1.62
1.3
1.6
0.52
0.50
e9/l
—
10
42
596
5867
2.20
1.60
32.3
18.8
4.50
4.50
e12/l
0.18
589
5777
32
207
1.58
1.60
1.1
1.1
8.21
4.81
u/ml
0.44
22
131
26
160
1.65
1.58
1.2
1.2
—
—
—
0
0
27
168
1.64
1.58
1.4
1.4
28.75
20.29
u/l
0.62
21
145
31
200
1.58
1.57
1.5
1.5
0.08
0.04
iu/ml
—
6
27
25
392
0.62
1.54
1.6
1.5
1.44
1.16
ratio
0.44
12
253
5
15
3.35
1.52
1.0
1.6
10.29
8.19
ug/l
—
5
15
9
38
2.39
1.46
1.1
1.2
—
—
—
0
0
6
22
2.74
1.43
1.2
1.5
—
17.60
—
0
5
14
74
1.91
1.40
1.7
1.4
—
—
—
0
0
26
392
0.65
1.36
1.6
1.5
1.21
1.21
ratio
0.02
12
253
26
392
0.65
1.36
1.6
1.5
0.79
0.96
ratio
2.30
12
253
48
643
0.72
1.34
1.6
1.7
3.61
3.37
mmol/l
0.71
31
450
26
386
0.66
1.28
1.6
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
35
2.30
1.27
1.1
1.1
—
—
—
0
0
29
196
1.50
1.24
1.1
1.1
0.72
0.72
u/ml
0.00
16
103
12
63
1.92
1.23
1.3
1.6
—
—
—
0
0
11
56
1.98
1.22
1.0
1.1
—
—
—
0
0
232
2084
1.18
1.22
1.8
1.9
1.40
1.34
mmol/l
0.39
197
1857
5
19
2.64
1.22
1.0
1.2
—
—
—
0
0
5
19
2.64
1.22
1.0
1.2
—
—
—
0
0
12
64
1.89
1.18
1.1
1.2
22.08
31.45
mg/l
1.21
12
49
14
79
1.79
1.18
1.3
1.1
6.38
12.33
u/ml
—
5
35
35
482
0.71
1.17
1.4
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
87
1.74
1.16
4.7
5.5
0.32
0.40
iu/ml
—
6
47
522
5042
1.26
1.16
4.9
4.6
2.87
2.82
mmol/l
0.64
492
4830
14
81
1.75
1.09
1.5
1.5
—
—
—
0
0
5
21
2.39
1.09
1.0
1.4
—
—
—
0
0
7
32
2.20
1.08
1.0
1.0
0.10
0.31
u/ml
—
7
32
11
59
1.88
1.08
1.8
1.4
—
—
—
0
0
17
105
1.64
1.07
1.4
1.4
—
—
—
0
0
15
90
1.68
1.05
1.4
1.5
—
—
—
0
0
20
130
1.56
1.04
1.4
1.7
—
—
—
0
0
5
22
2.28
1.03
1.2
1.9
—
—
—
0
0
5
22
2.28
1.03
1.4
1.5
—
—
—
0
0
11
60
1.85
1.03
1.8
1.4
—
—
—
0
0
11
60
1.85
1.03
1.8
1.4
—
—
—
0
0
11
60
1.85
1.03
1.8
1.4
—
—
—
0
0
10
53
1.90
1.01
1.1
1.1
—
68.00
—
0
7
11
61
1.82
0.99
1.8
1.4
—
—
—
0
0
7
36
1.96
0.97
1.7
1.6
—
—
—
0
0
7
36
1.96
0.97
1.7
1.6
—
—
—
0
0
7
36
1.96
0.97
1.7
1.6
—
—
—
0
0
12
69
1.75
0.97
2.3
4.6
1.91
2.39
ratio
—
7
36
11
62
1.79
0.94
1.0
1.1
195.73
202.35
mg/l
0.10
11
55
516
5002
1.22
0.94
4.4
4.1
1.45
1.51
mmol/l
2.38
488
4781
9
52
1.74
0.92
1.0
1.5
—
—
—
0
0
14
86
1.64
0.91
1.1
1.4
—
253.33
—
0
6
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
8
44
1.83
0.86
2.0
1.7
—
—
—
0
0
517
5023
1.20
0.85
4.6
4.2
4.72
4.75
mmol/l
0.27
495
4822
14
88
1.60
0.85
1.9
2.1
—
—
—
0
0
21
294
0.70
0.82
1.5
1.8
—
—
—
0
0
21
147
1.44
0.81
1.2
2.1
1.50
12.41
e6/l
1.39
14
106
18
122
1.49
0.81
1.3
1.3
—
—
—
0
0
24
173
1.40
0.80
1.2
1.3
—
—
—
0
0
0
25
0.00
0.79
0.0
2.2
—
—
—
0
0
0
25
0.00
0.79
0.0
2.2
—
—
—
0
0
58
477
1.24
0.78
1.1
1.0
—
—
—
0
0
20
140
1.44
0.78
1.3
1.5
95.20
149.84
au/ml
—
5
46
18
124
1.47
0.76
2.4
1.4
619.69
337.80
mu/l
0.76
13
105
12
184
0.65
0.75
1.5
1.3
—
—
—
0
0
9
54
1.68
0.74
1.1
1.1
—
—
—
0
0
5
24
2.09
0.74
1.8
1.1
62.54
202.15
pmol/l
—
5
24
21
150
1.41
0.74
1.2
2.2
15.14
130.78
e6/l
1.37
14
114
19
134
1.43
0.72
1.5
1.6
—
—
—
0
0
52
428
1.24
0.71
6.1
5.0
—
—
—
0
0
5
26
1.93
0.70
1.0
1.7
—
—
—
0
0
499
4855
1.16
0.69
27.0
15.1
332.29
332.51
g/l
0.24
499
4833
16
110
1.47
0.69
1.0
1.1
—
—
—
0
0
10
61
1.65
0.69
1.9
1.4
—
—
—
0
0
38
303
1.27
0.68
2.1
1.8
3.83
3.19
mg/l
0.31
30
211
19
136
1.41
0.67
1.0
1.1
—
—
—
0
0
7
43
1.64
0.67
1.1
1.1
—
43.20
—
0
5
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
41
499
0.81
0.63
3.5
3.7
33.31
31.91
%
0.38
32
362
5
30
1.67
0.61
1.0
1.4
0.00
28.86
u/ml
—
5
23
19
139
1.38
0.61
1.0
1.1
1.04
2.59
eliau/ml
—
8
66
11
72
1.54
0.59
1.1
1.1
—
—
—
0
0
27
338
0.79
0.54
1.4
1.7
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
1445.50
1467.28
miu/ml
—
6
39
19
248
0.76
0.52
2.5
1.9
—
—
—
0
0
482
4704
1.12
0.52
3.9
3.5
1.30
1.21
mmol/l
1.80
456
4473
11
75
1.48
0.51
1.1
1.1
—
—
—
0
0
6
41
1.47
0.50
2.2
1.4
102.50
71.29
umol/l
—
6
41
37
308
1.21
0.49
1.4
1.4
—
—
—
0
0
23
181
1.28
0.48
1.8
1.5
—
—
—
0
0
7
48
1.46
0.47
1.1
1.0
—
—
—
0
0
19
147
1.30
0.45
2.3
2.1
1.63
1.34
g/l
0.60
14
132
5
32
1.57
0.42
1.4
1.6
—
—
—
0
0
5
32
1.57
0.42
1.2
1.8
—
—
—
0
0
5
32
1.57
0.42
1.2
1.2
20.04
36.96
u/ml
—
5
32
8
57
1.41
0.42
2.0
1.6
—
—
—
0
0
29
240
1.22
0.42
3.5
2.9
0.51
0.79
ug/l
2.10
17
130
38
324
1.18
0.41
1.7
1.5
—
—
—
0
0
5
33
1.52
0.41
1.4
2.3
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
14.60
8.78
mm/h
—
5
37
24
199
1.21
0.35
1.0
1.1
1.47
2.35
u/ml
0.39
14
121
128
1200
1.08
0.33
2.8
4.0
4.75
9.29
mg/mmol
1.23
64
757
11
84
1.32
0.30
1.7
1.3
—
—
—
0
0
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
22
254
0.86
0.24
1.3
1.6
59.20
52.95
ug/l
0.32
22
254
5
39
1.28
0.23
3.0
1.9
102.20
106.31
mmol/l
—
5
39
5
39
1.28
0.23
1.6
1.4
—
—
—
0
0
7
93
0.75
0.22
1.1
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
0.80
—
0
10
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
37
335
1.11
0.21
3.0
4.3
2.62
8.64
ug/l
2.52
28
262
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
19
164
1.16
0.20
1.9
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
34
312
1.10
0.16
4.4
4.1
23.67
22.96
%
0.07
11
135
12
102
1.18
0.15
1.3
1.2
—
—
—
0
0
7
89
0.78
0.14
1.9
1.6
—
—
—
0
0
22
199
1.11
0.13
1.4
1.4
48.45
138.66
pmol/l
0.95
22
192
27
251
1.08
0.10
1.6
1.4
—
—
—
0
0
17
154
1.11
0.10
1.9
1.9
—
—
—
0
0
16
146
1.10
0.08
1.0
1.1
0.12
0.37
u/ml
—
6
62
5
63
0.79
0.08
1.8
1.5
—
—
—
0
0
43
411
1.05
0.08
1.5
1.4
—
—
—
0
0
9
100
0.90
0.06
2.9
2.0
12.29
13.27
%
—
9
100
443
4442
0.99
0.02
4.1
3.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
5.92
—
0
5
7
71
0.99
-0.00
1.3
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
48.01
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED | 2.061 [1.59, 2.68] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.094 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 2142 females with Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED | 2.024 [1.48, 2.77] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 1126 males with Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.212% | 0.457% |
| 5 | 1.159% | 2.853% |
| 10 | 2.828% | 6.949% |
| 15 | 5.402% | 12.6% |
| 20 | 9.606% | 20.54% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED – Congenital malformations of the musculoskeletal system, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data